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ABSTRACT 
 
Background: Periodontitis is a bacterially induced chronic inflammatory 
disease that destroys the supporting tissues of teeth. Clinical 
observations and experimental evidence indicates that there is a genetic 
influence of risk factors for periodontitis. A specific pattern of IL-1 
polymorphisms (known as the composite IL-1 genotype) has been found 
to influence the severity of chronic periodontitis.  
Objective: To evaluate the association between the IL-1 gene 
polymorphisms and the severity of periodontal disease in a selected 
Xhosa population of South Africa. 
Methods: Ninety-nine subjects, 35-60 years of age who were non-
smokers and free of systemic disease were enrolled in a case-control 
study depending on their periodontal status (healthy to mild vs. 
moderate to severe disease). A buccal smear was obtained from the 
patient; the DNA was isolated then amplified by polymerase chain 
reaction (PCR). Allele identification was either by real-time PCR or by 
the size of fragment after restriction digestion and separation in 
polyacrylamide gel. 
Results: Logistic regression analysis was conducted to estimate the 
effects of gender, age, plaque index, gingival index, number of teeth 
lost and the IL-1 allele status on the severity periodontal disease. IL-1A 
polymorphism had a statistically significant effect on the severity of 
periodontitis. The prevalence of allele 2 was 46.9 % in cases and 22 % 
in controls at the IL-1A +4845 locus, and 15.8 % in cases and 14.3 % 
in controls at the IL-1B +3954 locus.  
Conclusions: This study demonstrated that the IL-1 composite 
polymorphism is not related to the severity of periodontitis in the Xhosa 
population of South Africa. This supports the recent findings that the 
composite genotype does not show the same association in patients of 
different ethnic groups.  
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SUMMARY 
Periodontitis is a bacterially induced chronic inflammatory disease that 
destroys the bone and connective tissue attachment to the teeth. Host 
response to periodontal disease is a protective, as well as a destructive 
factor and the role of pro-inflammatory cytokines has been reported. 
A specific pattern of IL-1 polymorphisms has been found to be 
associated with increased risk for severe generalized periodontitis.  
Aim: The aim of this study was to evaluate the association between the 
IL-1 gene polymorphisms and the severity of periodontal disease in the 
Xhosa population of South Africa 
Materials & Methods: Ninety-nine subjects, 35-60 years of age non 
smokers, free of systemic disease were enrolled in a case-control study, 
depending on their periodontal status (healthy to mild vs. moderate to 
severe disease). A buccal smear was obtained from the patient; the 
DNA was isolated then amplified by PCR. Allele identification was either 
by real-time PCR or by the size of fragment after restriction digestion. 
Results: Interleukin-1A polymorphism had a statistically significant 
effect on the periodontal condition. The carrier rate of allele 2 at IL-1B 
failed to distinguish between cases and controls. Thus, 15.8 % of the 
cases and 14.3 % of the controls carried at least one #2 allele at the IL-
1B +3954 locus, and 46.9 % of the cases and 22 % of the controls at 
the IL-1A +4845 locus. Logistic regression analysis was conducted to 
estimate the effects of gender, age, plaque index, gingival index, 
number of lost teeth as well as Interleukin-1 allele status on the 
periodontal disease condition. 
Conclusion: The findings of the study demonstrated that the IL-1 
composite polymorphism is not related to the severity of periodontitis in 
the Xhosa population of South Africa. The findings supported the recent 
findings that the composite IL-1α-4845 and IL-1β +3953 genotype 
reported to be associated with severity of adult periodontitis in Northern 
European non-smokers does not show the same association in patients 
of other ethnic groups.  
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CHAPTER 1 
INTRODUCTION 
Bacterial pathogens are the primary etiologic factors in periodontal 
disease.1 The disease process is modified by several risk factors, 
including; smoking, systemic diseases and genetic influences.2  
Host response to periodontal disease is a protective as well as a 
destructive process and the role of pro-inflammatory cytokines, 
notably interleukin-1 and tumor necrosis factor in bone resorption and 
attachment loss has been reported.3   
Recent studies have demonstrated that a specific polymorphism in the 
interleukin-1 gene cluster is associated with severity of     
periodontitis.4, 5, 6  
Studies designed to estimate the genetic risk for periodontitis indicated 
that these diseases are etiologically complex and that both smoking 
habits and ethnicity are confounding factors .4, 7, 8  
The prevalence of periodontitis appears to vary between populations 
with different genetic backgrounds, and findings from one ethnic group 
may not be extrapolated to other ethnic groups. Perusal of the 
literature indicates that this is the first study to evaluate the 
prevalence of the interleukin-1 composite genotype and its association 
with chronic periodontal disease in a population of African ancestry, 
namely the Xhosa population of South Africa. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1- INTRODUCTION AND DEFINITIONS 
Periodontitis is a bacterially induced chronic inflammatory disease.1 
Toxins produced by bacteria in the plaque activate the body's 
inflammatory and immune mechanisms which can lead to the 
destruction of the bone and periodontal tissues supporting the teeth. 3  
Periodontal disease is  progressive, and it can be classified by the 
magnitude of tissue destruction as mild, moderate, or severe.9 
Approximately 10 -15% of the adult population have a severe 
generalized form of the disease, that might result in tooth loss or 
require surgical intervention. 10   
Smoking has been strongly associated with an increased prevalence 
and severity of periodontitis. Other reported risk factors of periodontal 
disease are age, diabetes, stress and malnutrition .3   
The clinical observations and experimental evidence indicate that there 
is a genetic component to risk for periodontitis in adults.2,4,5,11 Studies 
of identical twins demonstrated that genetics plays a significant role in 
the variability of chronic periodontitis.12 There is also evidence that 
aggressive periodontitis has a genetic component. However; this type 
of periodontitis of low prevalence in the population and as it tends to 
cluster in families, the likelihood of inheriting aggressive priodontitis 
may be high.13 
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Linkage and association studies 11 showed that genetic polymorphisms 
associated with risk for various forms of periodontitis in different 
populations were in genes that code for inflammatory cytokines such 
as interleukin-1 and tumor necrosis factor, immunoglobulin receptors, 
and the vitamin D receptor. 6,14,15, 16  
One of the primary components of the inflammatory and immune 
responses is cytokine production. Cytokines are peptide/protein 
immunomodulators that are produced by activated immune cells 
including T lymphocytes, B lymphocytes and monocyte/macrophages. 
These cytokines include interleukins (IL-1 through to IL-15), tumor 
necrosis factors (TNFs alpha. & beta.)  interferons (IFN alpha. beta. & 
gamma.) and colony stimulating factors (CSFs) for granulocytes 
and/or macrophages (CSF-G, CSF-M) 6, 14,15,16   
The IL-1 family consists of three genes: IL-1A (IL-1a), IL-1B (IL-1b) 
and IL-RN (IL-1 receptor antagonist). Cytokines such as (IL)-1b and 
(TNF) have an important role in collagen and bone destruction in 
periodontal disease. Other modulators such as prostaglandins (such as 
PG E2), and matrix metalloproteinases (MMPs) also play a significant 
role. 3,16,17 
Some studies have shown that allelic polymorphisms controlling the 
inflammatory and other immune responses in certain diseases with 
inflammatory components affects the susceptibility or severity of these 
diseases.5,16 Attempts have been made to elucidate the association of 
single nucleotide polymorphisms (SNPs) between patient populations 
with regard to specific disease patterns.14    
In a report by Kornman and co-workers it has been suggested that a 
specific pattern of IL-1 polymorphisms was associated with a 
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significantly increased risk for developing severe generalized 
periodontitis. This genotype includes two polymorphisms of the IL-1 
gene cluster on chromosome 2 and has been refered to as the 
composite genotype. 5,14, 16,18 
According to Kornman the composite interleukin –1 genotype was 
described as allele 2 at the IL-1A (-889) locus plus allele 2 at the IL-1B 
(+3953) locus.5 Another polymorphism at IL-1 (+4845) was found to 
be 100% concordant with the IL-1 (-889) locus, and technically it is 
less difficult to be assayed. The IL-1B polymorphism was renumbered 
to IL-1B (+3954) .18 It is now accepted that the composite interleukin 
–1 genotype is described as allele 2 ( Thymidine substitutes Guanine ) 
at the IL-1A (+4845) locus plus allele 2 (Thymidine  substitutes 
Cytocine) at the IL-1B (+3954) locus.18,19 
Kornman et al.4 reported that the IL-1 genotype is significantly 
associated with severe generalized periodontitis in non-smoking 
adults. In smokers, severe disease was not correlated with genotype. 4 
Several other studies were conducted in different populations that 
either reported similar results or challenged Kornman’s findings. 5,6, 15, 
20-23 
 
In this review the prevalence and etiological factors of chronic 
periodontitis are discussed to give a general understanding of the role 
of IL-1 polymorphisms as a potential risk factor for chronic 
periodontitis.  
No relevant information was found about the periodontal health and 
the relationship to  IL-1 polymorphisms in South African populations of 
African ancestry, in the last decade. This study investigated the 
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prevalence of Interleukin-1 genotype and its association with the 
periodontal disease status in the Xhosa population of South Africa.  
Definitions 
For more convenient reading the definitions are listed at the end of the 
thesis, see appendix A 
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2.2- PREVALENCE OF PERIODONTAL DISEASE 
Periodontitis, a chronic multifactorial disease in adults, is associated 
with gram-negative bacteria (see page 9). The most common form of 
periodontitis is chronic periodontitis, which has been reported to affect 
more than 30% of the population, and it has been claimed that about 
10 % of the adult population have a severe generalized form of the 
disease.10 Chronic periodontitis can be explained as a result of an 
interaction between the host immunoinflammatory response and 
gram-negative bacteria. 
 The general understanding about periodontitis was that it is 
universally prevalent in middle age people as a result of bacterial 
plaque accumulation on teeth and so preventative measures were 
directed at controlling the bacterial challenge. However, studies found 
that even with high plaque challenges, severity of periodonitits was 
variable.11  
In 1986, Löe and co-workers 24 conducted a study on the natural 
history of periodontal disease in man.24 Over a period of 15 years, they 
examined a group of male tea workers in Sri Lanka (age range 14 to 
31 years). These men did not follow any conventional oral hygiene 
measures and had no access to dental care; they presented with large 
amounts of plaque, calculus, and stains on their teeth, and almost all 
the gingival units were inflamed thus allowing the study of the natural 
progression of untreated periodontal disease. 
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On the basis of interproximal loss of attachment, it was found that 
81% of the men had moderate progression in attachment loss, 11% 
did not progress beyond gingivitis and the remaining group; 8% 
exhibited rapid loss of attachment, losing between 10 and 32 teeth 
over 15 years. 
The group exhibiting rapid progression had a mean loss of attachment 
of approximately 9 mm at age 35 years, which increased to 
approximately 13 mm at age 45 years, with an annual rate of 
destruction of 0.1 to 1.0 mm.  
In individuals exhibiting moderate progression, the mean loss of 
attachment was approximately 4 mm at age 35 years and 7 mm at 
age 45 years, with an annual rate of destruction between 0.05 and 0.5 
mm. The mean loss of attachment in individuals with no progression of 
disease was 1 mm at age 35 years, with an annual rate of destruction 
between 0.05 and 0.09.  
Conclusions that the authors drew from this study are that 
periodontitis could be a group of diseases that differ in extent and 
severity rather than a single disease entity. Severe periodontitis was 
found in a small percentage of the population and a fraction of persons 
were immune to periodontitis. Also contrary to popular theory not all 
cases of gingivitis will proceed into periodontitis. 
Several studies indicated that other factors may play a significant role 
in periodontitis. 25-27 
Clinical differences in the prevalence and severity of chronic 
periodontitis could be due to genetic host’s makeup. A patient’s 
resistance to periodontal disease is influenced by his genetic make-up, 
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and this has been determined from a variety of sources: studies of 
twins, studies of aggressive periodontitis, natural history studies, and 
cytokine genetics studies. 2,4,5,11,12,13,24 
These findings have shifted the focus of periodontal research over the 
last few decades into the host susceptibility risk factors such as 
genetic factors to periodontal disease. 
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2.3- RISK FACTORS OF PERIODONTAL DISEASE 
2.3.1- ROLE OF BACTERIA IN PERIODONTAL DISEASE       
Introduction 
It is generally accepted that the primary etiologic factor for periodontal 
disease is bacterial plaque.28 The composition of dental plaque varies 
considerably between patients and among different sites in the same 
patient. 
It has been demonstrated that specific elements of host susceptibility, 
such as an individual’s systemic disease state and immune response, 
are important factors affecting the progression of disease.25-27 
 Studies have identified three bacterial species to be consistently 
prevalent in plaque associated with severe disease. These bacteria are 
now officially designated as ‘periodontal pathogens'. These are 
Actinobacillus actinomycetemcomitans(Aa), Porphyromonas 
(Bacteroides) gingivalis (Pg) and Tannerella forsythia(Tf). 28-31  
Other species of bacteria likely to contribute to the etiology of 
periodontitis both in adults and children disease are Treponema 
denticola, Selenomonas and Eikenella species. 29,30    
Recent work suggested that bacterial species exist in complexes within 
subgingival plaque, and it is these microbial complexes that contribute 
and exacerbate the disease processes.28-30 It seems most likely that 
the organisms benefit from nutritional and metabolic 
interdependencies and collectively are able to resist the host defenses 
more efficiently. The most significant complex is that which includes P. 
gingivalis, T. forsythia and T. denticola because species in this complex 
 
 
 
 
 10
increase in numbers and prevalence with increasing pocket depth and 
bleeding on probing.30  
A larger complex of organisms is implicated with advanced 
periodontitis include the black-pigmented Prevotella intermedia   
(formerly Bacteroides intermedius) and Prevotella nigrescens, 
Peptostreptococcus micros and Fusobacterium nucleatum.29,30   
A. actinomycetemcomitans serotype b isolates are uniquely associated 
with aggressive periodontitis. These isolates are rarely found within a 
specific bacterial complex, but occasionally they cluster with 
A.actinomycetemcomitans serotype a, which in turn is found in 
association with Eikenella corrodens and various Capnocytophaga  
species.  
Initiation and progression of disease 
Dental plaque is a soft deposit that accumulates on teeth. Plaque can 
be defined as a complex microbial community, with approximately 1010 
bacteria per milligram. It has been estimated that as many as 400 
distinct bacterial species may be found in plaque. In addition to the 
bacterial cells, plaque contains a small number of epithelial cells, 
leukocytes, and macrophages. The cells are contained within an 
extracellular matrix, which is formed from bacterial products and 
saliva. The extracellular matrix contains proteins, polysaccharides and 
lipids.28, 30  
Bacterial plaque is essential for the initiation and progression of 
periodontitis. However, it now appears that once the bacteria are 
present, the amount of periodontitis that a patient develops is due to 
factors related to the body's response to the bacterial challenge. In 
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this context the value of plaque sampling in non-responding patients is 
of growing interest.30 One principal reason for the differences in how 
patients respond to plaque, manifest disease, and respond to 
treatment is that there are different types of plaque. 
The fastest growth of the plaque occurs at the gingival margin, where 
plaque accumulations usually are visible after several days. This 
plaque may, in some instances, provoke gingivitis where Spirochetes 
and Actinomyces viscosus are prominent members of the plaque flora. 
28,30 If this plaque remains undisturbed, the flora gradually shifts 
toward an anaerobic, Gram-negative flora which includes black 
pigmented bacteroides and several types of spirochetes. 28 The 
increase in growth potential of these anaerobic organisms can be 
explained by the low oxidation-reduction potential of the aged plaque 
and by nutrients derived from the inflammatory exudate at the site.                           
Disease episodes ensue from an upset in the balance between bacteria 
and host, such as changes in the relative numbers and pathogenic 
potential of certain bacteria, or modulation of host factors.                                        
The process of periodontal disease initiation is not fully understood but 
it seems that the so-called ‘primary colonizers’, including 
Streptococcus, and  Actinomyces, which bind strongly to saliva-coated 
surfaces and to gingival epithelial cells, are recognized by later 
(secondary) colonizers, which include some periodontal pathogens, 
with the former acting as a base for the latter to adhere to. 28,30 
The primary colonizing bacteria also create an anaerobic environment 
and provide nutrients for the late colonizers.  
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Bacteria in the plaque, touching the tissue, elaborate various 
compounds, such as hydrogen sulfide, ammonia, amines, endotoxins 
lipopolysac-charide (LPS), enzymes (such as collagenases) and 
antigens, all of which penetrate the gingiva and activate host cells 
(i.e., fibroblasts, macrophages, and polymorphonuclear leukocytes 
[PMNs]) to secrete proinflammatory cytokines such as interleukin-1 
beta (IL-Ib) and tumor necrosis factor alpha (TNF-a). 28,32 This 
inflammatory response, although protective, appears to be responsible 
for a net loss of periodontal supporting tissue, and leads to periodontal 
pocket formation, mobility of the teeth, and eventual tooth loss.  
Clinical evidence has demonstrated that not all individuals have the 
same response to similar amounts of plaque accumulation. There are 
patients with moderate and advanced disease who have very little 
plaque while other patients with little disease have large amounts of 
plaque. Most importantly, large studies that have assessed the 
relationship of plaque quantity, as well as the presence of specific 
bacteria, to the severity of periodontitis indicate that a substantial part 
of the variation in clinical severity of disease may be explained by 
factors other than the bacterial challenge.  
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2.3.2- THE RELATIONSHIP BETWEEN AGE AND PERIODONTAL 
DISEASE 
The prevalence of periodontal disease increases with age.33, 34 This 
could be due to the presence of the potential risk factors for a longer 
period or due to the consequences of aging. Although aging is 
associated with metabolic changes, it has not been directly linked with 
periodontal attachment loss. While the rate of periodontal destruction 
increases after the age of 70 years, up to that age, the rate of 
attachment loss is the same.35  
Studies of natural history of periodontitis showed that patients might 
have different rates of periodontal destruction and therefore the 
amount of periodontal loss may be different at a specfic age in 
different individuals. 24 An important theory is that some risk factors 
might be potentiated in certain age groups. 4 
2.3.3- SMOKING AND PERIODONTAL DISEASE 
Smoking is strongly associated with periodontitis. It has been reported 
that in adults aged 19-40 tooth loss is strongly associated with 
smoking more than 15 cigarettes a day.36 Grossi and co-workers37 
found that, a light smoker (<10 cigarettes a day) was 2.0 times more 
likely to have alveolar bone loss as compared to a nonsmoker. In a 
heavy smoker (>10 cigarettes a day), the odds ratio was 7.3. That 
report revealed a dose–response relationship between smoking and 
bone loss. 
The biological basis for smoking as a risk factor for periodontal disease 
is evident and results in inhibition of neutrophil function in saliva and 
connective tissues, 38 suppression of IgG2 antibody response and 
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increase of the release of (IL-1ß), which greatly affects osteoblast 
function.39 In addition, some ingredients in tobacco constrict the 
gingival blood vessels, which accounts, in part, for the lack of bleeding 
on probing observed in most smokers. It has been reported that the 
response to periodontal therapy, whether surgical or non surgical, is 
less in smokers than in non-smokers, and a higher recurrence to 
disease was observed in smokers.40-41 
 
2.3.4- EFFECT OF DIABETES ON PERIODONTAL DISEASE 
The likelihood of periodontal disease increases when diabetes is poorly 
controlled.42  People with diabetes mellitus are more likely to be 
edentulous than people without the disease (odds ratio 15). On the 
other hand well-controlled diabetics, with good oral hygiene and on a 
regular supportive periodontal treatment have the same chance of 
developing severe periodontitis as healthy subjects.  
The biological mechanism is complex. The small blood vessels of 
people with diabetes have thickened basement membranes, thus 
leading to a reduction in transport across the vessel walls. There is a 
reduction in collagen production by gingival and periodontal 
fibroblasts. In addition, high levels of pro-inflammatory mediators 
responding to endotoxin from gram-negative bacteria lead to an 
increase in collagen breakdown. 42 
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2.3.5-GENETIC FACTORS AND PERIODONTAL DISEASE 
Introduction 
 Chronic periodontitis appears to be multifactorial, meaning that 
susceptibility involves multiple genes and environmental factors.  
The genetics of the more common chronic forms of periodontitis 
appear to be complex. There is no clear evidence of a simple 
Mendelian pattern of genetic transmission that would support an 
etiologic role for a single gene mutation in chronic periodontitis. 
The search for susceptibility genes for complex diseases is becoming 
more extensive, by non-molecular approaches (segregation analysis 
by studying twins, family studies, or unrelated individuals in a case-
control design), and by molecular approaches (family studies or case-
control approaches coupled with analyses of genetic marker 
polymorphisms). However, molecular approaches offer better 
analyses to assess whether specific genes or candidate regions are 
associated with complex diseases such as chronic periodontitis. 43  
Complex diseases may be studied using both molecular and non-
molecular approaches to more completely understand their genetic 
and environmental nature. 
It has been reported that specific mutations were able to define the 
genetic basis of some rare syndromic conditions, for example, the 
cathepsin C gene in Papillon-Lefèvre syndrome, 44 the CHS gene in 
Chédiak-Higashi syndrome, 45 and the beta-2 integrin chain gene in 
leukocyte adhesion deficiency type 1.46  
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While understanding rare forms of disease may expand the 
understanding of periodontitis, it may not provide specific genetic tests 
to guide practitioners in managing the majority of patients.47 
There have been remarkably few studies of chronic periodontitis in 
families, and although some studies reported a significant sibling 
effect for clinical parameters of disease in non-twins, 48 others have 
concluded that the basis of this similarity is the shared environment or 
culture, but not genes.49-51  
Studies of aggressive periodontitis 
Familial aggregation of severe early-onset forms of non-syndromic 
aggressive periodontitis has been noted in the literature. 2, 52, 53 
Although heritable differences among individuals appear to play an 
important role in risk for early-onset periodontitis (EOP), the specific 
nature of genetic risk is unclear. These conditions are more complex 
than the simple Mendelian syndromes.54-56 Some studies suggested 
familial transmission of juvenile periodontitis as an autosomal trait 
(both dominant and recessive transmission), consistent with a gene of 
major effect.57 Boughman and coworkers reported localization of an 
EOP gene to chromosome 4q, apparently providing direct evidence 
for the existence of a gene of major effect for EOP in a genetically 
unique population isolate.58 Segregation analysis and linkage analysis 
indicate that there are multiple different genetic forms of aggressive 
periodontitis but it is currently unclear how many genes may be 
involved in aggressive periodontitis.57-60  
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Aggressive periodontitis is rare and it is difficult to collect enough 
information from families to provide sufficient evidence to identify 
disease-related genes.55, 56 
It appears that some genes of major effect are associated with 
aggressive periodontitis and some rare syndromic forms of 
periodontitis. There is evidence that some genes may modify the 
severity of periodontal disease. Environmental and microbial agents 
also modify the risk and expression of disease. 
Some studies suggested that a single gene of major effect may be 
etiologically responsible for chronic periodontitis, while other studies 
support a more complex genetic etiology and it is likely that the 
synergistic effect of multiple genes is pivotal of disease susceptibility in 
chronic periodontitis.2, 61 Furthermore, these models suggest that 
these genes interact with other genes and with environmental factors 
over a substantial period of time to ultimately influence 
susceptibility.62 
The genetic influence in chronic diseases is difficult to study since so 
many confounding factors are interacting during the progress of the 
disease. Besides, it is not practical to study families in different 
generations in chronic diseases. Therefore, in chronic periodontitis with 
an older age of onset, evidence for a genetic component for 
periodontitis susceptibility comes primarily from twin studies.2, 11, 12  
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Studies of Twins 
The most convincing demonstration of a genetic influence on adult 
periodontitis came from studies of twins by Michalowics and 
coworkers.11, 12 Twin studies are typically used to estimate 
heritability for a trait or disorder. In general terms, heritability is the 
proportion of the variance in the population that is due to individual 
differences in genetic makeup. 
Comparison of concordance rates of disease (i.e. if both twins in a pair 
are affected, the concordance rate is 100%) in monozygotic or 
dizygotic twins is the classic method for determining whether familial 
patterns of disease are the result of common genetic or common 
environmental factors. The higher the concordance rate is in 
monozygotic twins compared with dizygotic twins, the more 
influencing are the genetic factors. The concordance rate in 
monozygotic twins is not expected to be 100%, due to environmental 
effects.63 
Studies on periodontal disease in twins suggested that approximately 
50% of susceptibility may be due to genetic factors.11 
Michalowicz and coworkers12 assessed the effect of environmental and 
host genetic factors to the clinical parameters of periodontal disease in 
adult twins.12 The study group included 77 monozygous twins and 33 
dizygous twins. A significant genetic component was identified for 
plaque, gingivitis, probing depth, and attachment loss based on ratios 
of within-pair variances or heritability estimates. It was found by 
heritability estimates that genetic factors resulted in a population 
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variance between 38 and 82% for the studied clinical parameters of 
disease.12  
Another study by Michalowicz and coworkers12 determined that the 
population variances for alveolar bone height (between-pair and 
within-pair) of the monozygous and dizygous twins were similar.12 
Calculated intraclass correlations and heritability estimates were for 
the reared-together monozygous (0.70) for dizygous twins (0.52), and 
for the reared-apart monozygous twins (0.55). The study indicated 
that there is significant genetic variance for alveolar bone height in the 
studied population. 64  
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2.4- IMMUNOLOGY OF PERIODONTAL DISEASE 
2.4.1- INTRODUCTION 
The host defense response to pathogens depends on the immune 
system and there are many genetic loci that have been associated with 
the immune response of the host to microbial infection. The most 
studied genetic factor is the major histocompatibility complex (MHC) 
on chromosome 6, which defines the HLA system that is involved in 
many interactions between the cells of immune response.  
Gene polymorphisms for Fc-gamma receptor (CD32 and CD16) can 
result in reduced phagocytic capacities, which provide a mechanism for 
heritable susceptibility to microbial infections. Genetic polymorphisms 
in Fc-gamma receptors have been associated with both early-onset 
periodontitis and refractory periodontitis.65 
The role of IL-1 in the immunology of the periodontal disease will be 
discussed as the link between the genetic polymorphisms (the 
genotype) and the periodontal disease status (the phenotype). 
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2.4.3- ROLE OF INTERLEUKIN-1 IN PERIODONTAL DISEASE 
Chemicals in the tissues that provide communications between cells 
are generally referred to as cytokines. The role of inflammatory 
cytokines has been studied extensively in periodontal diseases.66  
An important cytokine (IL-1) plays a critical role in many different 
systems in the body and has been strongly implicated in the risk and 
severity of adult periodontitis. 
The possible roles of interleukin 1 have recently received considerable 
attention. IL-1 facilitates the flow of inflammatory cells into sites of 
infection; stimulates eicosanoid release by monocytes and 
fibroblasts; stimulates matrix metalloproteinases; promotes bone 
resorption; and contributes to the inflammatory cascade of the 
microbial immune response. It also activates specific protective 
mechanisms and is involved in wound healing and bone and connective 
tissue metabolism. 3, 25, 26,43,67,68 
IL-1 levels have been reported to be elevated in periodontal tissues 
and gingival crevicular fluid associated with periodontitis. Higher 
production of these cytokines has also been associated with response 
to infection, where local induction of IL-I and TNF facilitates the 
elimination of the microbial invasion. However, classic studies also 
report that in some infectious conditions very high levels of monocytic 
cytokines are produced and initiate a cascade of concomitant events, 
such as tissue catabolism, vascular reactivity, and hypercoagulation, 
with damaging effects on the host. 15, 69 
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The relationship between IL-I and periodontitis has been extensively 
reviewed by Offenbacher.3 While the inflammatory process, in general, 
increases the local tissue levels of IL-I, differences between people in 
cytokine production rates have been fixed, which indicates that some 
people are more likely to produce cytokines upon stimulation.3 
IL-I genes (IL-IA, IL-IB, and IL-IRN) cluster on chromosome 2q. 13 
Interleukin- IA and IL- 1 B encode for the proinflammatory cytokines 
IL- Ia and IL-Ib, and IL-IRN encodes IL-lra, a receptor antagonist. 
Several genetic polymorphisms have been identified in the genes of 
the IL-I cluster. Pociot and coworkers17 reported that a TaqI 
polymorphism in the interleukin-1β gene correlated with secretions 
of interleukin-1β in vitro.17 Other studies found that it was correlated 
to endotoxins produced by Gram-negative bacteria.69              
Kornman and coworkers.4 reported that the presence of a composite 
genotype (allele 2 at two interleukin-1 gene polymorphisms) was 
associated with increased severity of periodontal disease in adult non-
smokers of Northern European ancestry.4 This was based on the 
premise that patients with the composite IL-I genotype have higher 
levels of IL-I in the gingiva than those observed in genotype-negative 
patients.  
Engebretson and coworkers15 have determined the levels of IL-1a and 
IL-1b in gingival biopsies and the levels of IL-1b in gingival crevicular 
fluid (GCF).15 The IL-1 genotype positives had higher levels of IL-1b in 
GCF, and the greatest differences being recorded between genotype-
positive and genotype-negative patients in sites of minimal probing 
depth. 15   
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Gingival tissue levels of IL- 1b were also higher and levels of IL- 1a 
were higher in genotype-positive patients. These findings were 
dramatic and indicate that IL-1 genotype-positive patients will have 
higher levels of IL-1 in periodontal tissues when there is a bacterial 
challenge.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24
2.5- GENOTYPE PREVALENCE IN DIFFERENT 
POPULATIONS 
As polymorphisms originally arise from mutations the frequency of 
genetic polymorphisms often varies among different ethnic groups. 
Therefore, it is necessary to determine the prevalence of specific 
alleles in ethnic categories to determine if information derived from 
one group can be extrapolated to another. 
In general terms, pathogenic gene mutations are rare alleles that 
dramatically affect the expression or function of a gene product, so 
that they are deterministic of disease. Genetic mutations underlie most 
simple genetic diseases. In contrast, complex genetic diseases may 
result from the combined effect of multiple functional genetic 
polymorphisms interacting with each other and with environmental 
factors to such an extent that over time, they modulate disease risk. 
In this complex disease model, a single functional genetic 
polymorphism associated with disease (at a population level) is not 
sufficient to cause disease, and therefore itself is not deterministic of 
disease. Consequently, such functional polymorphisms may be found 
in individuals with no evidence of disease and who may not be at great 
risk for disease. A fundamental characteristic of this genetic model is 
that such genetic polymorphisms are more frequent in the population 
than mutations, and the correlation between genetic polymorphisms 
and disease is generally much weaker than the relationship between a 
functional mutation and disease phenotype.12  
When studying the genetic basis of a disease, it is important to clarify 
the genetic model of disease and to apply appropriate statistical tests 
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to determine the degree of association of a specific gene in individuals 
with disease and also in individuals without disease. 
Several studies have indicated that 28 to 44 percent of Caucasians 
possess the composite genotype 4, 70-72 Reported rates in the literature 
on the carriage of allele 2 at the IL-1B +3954 locus are 44.1%, 
40.6%, and 33.7%. 4,6,73 In the IL-1A −889 locus, which is essentially 
100% concordant with the IL-1A +4845 locus, allele 2 carriage rates 
were shown to be 50.5%  and 40.6%. 4, 6 It becomes increasingly 
clear, however, that such rates should be expected to vary greatly 
between ethnically and/or racially distinct populations. In contrast, 
Armitage and colleagues8 revealed allele 2 carriage rates of 3.3% (IL-
1B +3954) and 17% (IL-1A +4845), and a prevalence of the positive 
composite genotype of only 2.3%.8 Furthermore, Walker and 
colleagues13 reported that less than 15 percent of African-Americans in 
their study population were genotype-positive. 13  
 The positive composite genotype was found to occur at rates of 23% 
and 35% in 2 samples of periodontally healthy subjects, one 
predominantly consisting of Hispanics and the second comprising both 
Caucasians and African Americans. 74, 75 
It is clear that the prevalence of allele 2 at both the IL1A+4845 and 
IL1B+3954 loci is different in different populations. Thus, it can be 
concluded that the prevalence of specific genotypes may vary among 
different ethnic groups, and information derived from one group can 
not be extrapolated to another without verification of its accuracy. 
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2.6- CORRELATION BETWEEN INTERLEUKIN-1 GENOTYPES 
AND CLINICAL CONDITIONS 
2.6.1- IL- I POLYMORPHISMS AND CHRONIC PERIODONTITIS 
Since Kornman et al.4 in 1997 several studies explored the relationship 
between IL-1 polymorphisms and periodontitis but the results were not 
unanimous in supporting or refuting a positive relationship between 
presence of the composite genotype and the severity of periodontal 
disease. 4,6,7,8,72,73,76 
Several studies have evaluated the correlation between bone loss and 
genotype status and reported an association between genotype 
positivity and the development of severe periodontitis. 
Kornman and colleagues4 concluded that nonsmokers with a specific  
genotype were 6.8 times more likely (6.8 odds ratio) to have severe 
periodontitis than genotype-negative patients. However, 14 (38 
percent) of 37 patients with moderate disease and 10 (23 percent) of 
44 healthy patients in their study also were genotype-positive (that is, 
false positive findings).  
The association between severe periodontitis and the genetic 
polymorphism in the IL- 1 genes was present only when smokers were 
excluded, which confirmed the importance of smoking as a risk factor 
for periodontitis. This was the first study that identified a genetic 
polymorphism that corresponds with a phenotypic immune response 
variable (IL- 1 production) in chronic periodontitis patients.4 The IL- 1 
genotype identified in this study appears to be a marker of a strong 
biological change that results in severe periodontitis, without regard to 
the amount of bacterial challenge as suggested by Offenbacher.3 The 
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first findings indicate that the significant association between the IL-1 
genotype and severity of periodontitis did not require any adjustments 
for the amount of bacterial plaque. The combination of having either 
the specific genotype or smoking accounted for the majority (86%) of 
severe cases of periodontitis. The IL-1 genotype was a very strong 
predictor of severe periodontitis in non-smokers aged 40 to 60 years 
(odds ratio 18.90). Among similar-aged individuals with mild 
periodontitis, 84% were genotype negative, which indicates the 
importance of an age factor on periodontal disease. 4 
It is noteworthy that the association between the genetic 
polymorphism in IL- 1 genes with severe periodontitis was only 
evident when smokers were excluded. This data supports the 
importance of other environmental factors, such as smoking, as a risk 
factor for periodontitis.4 The association of severe periodontitis with 
smoking and the IL-1 genotype suggests that both factors play an 
important role in the pathogenesis and clinical course of adult 
periodontitis. Smoking, by itself, is a strong risk factor for more severe 
periodontitis. It is therefore reasonable to expect that some IL-I 
genotype-negative patients who are heavy smokers will be susceptible 
to more severe periodontitis. This will certainly confuse the data 
analysis of research studies unless this factor is taken into account in 
the analysis. 
McDevits and colleagues 7 reported that genotype-positive patients 
were 3.75 times more likely to have moderate-to advanced 
periodontitis than were genotype negative patients. On the other 
hand, Mark and colleagues,77 found no relationship between genotype 
status and the presence of mild-to-moderate periodontitis. 
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Elevated tissue and gingival fluid levels of IL-I b in particular have 
been repeatedly associated with the severity of periodontitis. 
Gore and colleagues 6 reported a significant association between the 
IL-1 B polymorphism and severity of disease.6 In their study, the 
composite genotype did not offer advantages over just the IL-1B 
markers. Such differences among the studies are not surprising as the 
undertaken genetic studies had small numbers of subjects. 
 In most of the populations that have been tested, the composite 
genotype occurs in approximately 30% of individuals.4 Although it is 
expected that the IL-1 genotype will have the same relationship to 
disease in all populations, the IL-1 genotype may be found less 
frequently in some populations than in Caucasians. 
It is also possible that other genetic factors may play a role in other 
ethnic groups.  
Researchers have noted different genetic polymorphisms associated 
with chronic periodontitis and aggressive periodontitis.13,43,78 The 
finding that the prevalence of allele 1 and not allele 2 of the 
IL1B+3953 locus was higher among people with aggressive 
periodontitis has been interpreted by several authors to indicate there 
may be genetic differences related to different types of periodontal 
diseases.13,43,78 Other explanations for these results include the 
possibility that other genes closely linked to the tested IL-1 
polymorphisms may be etiologic for periodontal disease 
susceptibility.32 
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 At present, it seems reasonable to expect that, as with risk factors for 
cardiovascular disease, multiple factors such as IL-I genotype and 
smoking carry increased risk of more severe disease. It is likely that 
larger studies will help to define the magnitude of interactions between 
smoking and the IL-I genotype as well as other risk factors. 
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2.6.2- RELATIONSHIP BETWEEN INTERLEUKIN-1 BETA LEVEL 
AND GENOTYPE STATUS 
The biological model that explains the relation between the genetic 
polymorphisms and the periodontal disease status is that the level of 
IL-1ß secreted in the crevicular fluid and periodontal tissues is related 
to genetic polymorphisms, specifically, that allele 2 (homo- or 
heterozygous) of IL-1B is associated with an increased potential to 
secrete IL-1ß after bacterial stimulation.  
This hypothesis was based on the in vitro work of Pociot, 17 who found 
that people with allele 2 at the IL1B+3953 produced increased 
amounts of IL-1ß.  This finding was not consistent in several other 
studies.27, 28, 30, 38-41 For example, Engebretson and colleagues15 found 
that genotype-positive patients had an elevated level of IL-1ß in the 
gingival crevicular fluid from shallow pockets (less than 4 millimeters), 
and not in deeper probing depths (deeper than 4 mm). Mark and 
colleagues77 also noted that the level of IL-1ß was not related to 
genotype status. Other investigators who examined the levels of IL-1ß 
and a single polymorphism at allele 2 of the IL1B+3953 locus also 
reported no significant relationship with regard to the level of IL-1ß.39, 
40 
It appears that the relationship between genotype status and the level 
of IL-1ß is not completely understood, and that polymorphisms 
detected by the genetic susceptibility test cannot be used to reliably 
predict which patients will manifest elevated levels of IL-1ß. 
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2.6.3- IL- I POLYMORPHISMS AND BLEEDING ON PROBING 
Lang and colleagues70 assessed the relationship between IL-1 
polymorphisms and bleeding on probing in patients receiving 
maintenance therapy after periodontal surgery, to determine if a 
correlation existed between the incidence of bleeding on probing and 
the presence of the positive genotype. Statistically, no relationship was 
found between bleeding on probing and the composite genotypes 
when smokers were included. However, in non-smokers, a statistically 
significant more bleeding was found in genotype-positive patents.  
This finding may be due to the fact that smoking is a risk factor for 
periodontitis, and it is not possible to determine if genetic assessments 
reveal patients who are predisposed to develop a more pronounced 
host response to a microbial challenge.24 Goodson and colleagues75 
also noted an increased amount of bleeding on probing among 
genotype-positive patients in a gingivitis study. Other researchers 
found that among untreated16, 26 and treated patients, 20, 27 there was 
no correlation between the genetic susceptibility test results and the 
amount of bleeding on probing.28 Different levels of oral hygiene, 
professional maintenance therapy and small study populations could 
account in part for these conflicting results.  
Thus, it can be concluded that the relationship between bleeding on 
probing and the patient’s genotype is also conflicting, and studies have 
not verified that individuals with the associated genotype are more 
prone to develop increased bleeding on probing. 
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2.6.4- IL- I POLYMORPHISMS AND TOOTH LOSS 
 McGuire and Nunn have reported an increased susceptibility to tooth 
loss after periodontal therapy in IL-1 genotype-positive patients.72 
Ultimately, the aim of performing dental procedures is to maintain 
teeth in a state of health and comfort for the life of the patient. Thus, 
it would be beneficial to be able to predict which people are at 
increased risk of losing teeth, so that this information could be 
incorporated into a patient’s risk profile. To test this concept, McGuire 
and Nunn72  performed a retrospective study, genotyping 42 patients 
they had followed up over 13 years.72 They reported that genotype 
positive patients were associated with a 2.7 times greater chance of 
losing teeth as a result of periodontal problems. The odds ratio might 
have been even higher in a group of patients who did not comply with 
maintenance recall appointments. 
On the other hand, the study results were unclear with regard to the 
number of teeth that were lost among smokers and nonsmokers and 
the number of teeth were lost per patient. It is interesting that 26 (62 
percent) of 42 patients with periodontal disease in this investigation 
were genotype-negative which is the opposite of what would be 
expected in a group of patients in a periodontal practice. 
In contrast, several other investigators genotyped patients who had 
been monitored during maintenance therapy for 10 or more years 
after periodontal treatment and did not find an increased incidence of 
tooth loss among those who were genotype positive.74, 76, 80 Thus, 
conflicting data preclude the concept that genotype assessments could 
help predict which patients are predisposed to losing teeth as a result 
of periodontitis. 
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2.6.5- RELATIONSHIP BETWEEN GENOTYPE AND MAINTENANCE 
OF CLINICAL ATTACHMENT AFTER PERIODONTAL THERAPY 
A study that involved periodontal treatment showed a synergistic risk 
when a patient is both a smoker and is IL-1 genotype positive.43 
Another study suggested that genotype-positive patients were more 
prone to develop additional clinical attachment loss after treatment 
than were genotype-negative patients.20 
A prospective study conducted over five years by Cullinan and 
colleagues22 evaluated the relationship between periodontitis and the 
IL-1 genotype. They concluded that IL-1 polymorphisms may be a 
contributing risk factor for periodontal disease progression, but are not 
essential for it to occur, and by themselves may have only a small 
effect.  
It seems reasonable to assume that if the IL-I genotype is associated 
with more severe disease; the genotype may also influence response 
to therapy. 
Data from McGuire and Nunn validate that assumption. 72 This study 
determined that the significant predictors of tooth loss in periodontal 
patients who were monitored for 14 years after active therapy were 
smoking (increased risk for tooth loss where heavy smokers had a 
288% increased risk of losing teeth after therapy as compared to non-
smokers or light smokers) and the IL-I genotype (increased risk for 
tooth loss of 2.66). Patients who were both heavy smokers and IL-I 
type positive were 7.7 times more likely to lose teeth after periodontal 
therapy than all other patients. It is relevant that even in IL-I 
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genotype-positive patients, conventional periodontal therapy and good 
maintenance care allowed the successful retention of most teeth. 72 
Studies so far have shown evidence that IL-polymorphism analysis can 
provide valuable insight into an individual patient’s likely response to 
various interventions. However, several other clinical trials that 
monitored patients after periodontal therapy did not find a greater 
predilection for attachment loss among genotype-positive patients 
treated nonsurgically34, 35 or surgically.34 Therefore, it cannot be 
concluded that genotype-positive patients are more susceptible to 
develop additional attachment loss after periodontal therapy.  
Additional studies are necessary to provide greater insight into the 
relationships between genetic factors and periodontal and restorative 
therapy. The composite polymorphism marker is diagnostic; and may 
be used as a prognostic test to identify individuals who have a much 
higher susceptibility to adverse reactions to plaque.67 
The finding of the association between the IL-polymorphism and an 
increase in IL- I b production and more severe periodontal disease is 
consistent with the current model of how genetic factors influence 
common chronic diseases. If this model is applied to periodontitis, it 
would involve a disease initiating factor, which would probably be 
specific bacterium  and modifiers of disease mechanisms that explain 
the clinical severity, including certain systemic diseases, smoking, 
psychosocial factors, and the IL-I genotype. 
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2.6.6- IL- I POLYMORPHISMS AND IMPLANT LOSS 
 Genotyping might be able to predict survival for implants. To 
investigate this possibility, Wilson and Nunn81 assessed the 
relationship between IL-1 genotype and implant loss. They found no 
increased loss of implants among patients who were genotype-
positive.81 Siervo and colleagues82 confirmed this finding. Rogers and 
colleagues83 performed IL-1 genotyping on 119 white subjects and 60 
white healthy control subjects. The investigators concluded that the 
simultaneous presence of allele 2 at the IL1A-889 and IL1B+3953 loci 
was not found more often among subjects with early onset or adult 
periodontitis or among subjects with failed implants. Thus, similar to 
tooth loss, the current data do not support the assumption that dental 
implants are at greater risk of being lost among genotype-positive 
people. 
Finally, The Xhosas are part of the southern Nguni African migration 
and they are well established African population in the Eastern Cape 
and Western Cape provinces in South Africa.85 This study evaluated 
the prevalence of interleukin-1 polymorphisms and its association with 
the periodontal disease status in the Xhosa population of South Africa. 
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CHAPTER 3 
AIMS AND OBJECTIVES 
3.1 – AIM OF THE STUDY 
The aim of this study was to determine the prevalence of the IL-1a 
and IL-1b polymorphisms in the Xhosa population of South Africa, as 
well as to determine whether or not there is an association between 
these polymorphisms and the severity of periodontal disease. 
 
3.2 – OBJECTIVES OF THE STUDY 
The objectives of this study were to: 
- Evaluate periodontal health status in the Xhosa population of South 
Africa 
- Determine the prevalence of IL-1A +4845 polymorphisms in this 
population. 
- Evaluate the association between IL-1A polymorphism and severity 
of chronic periodontitis  
- Determine the prevalence of IL-1B +3954 polymorphisms in the 
Xhosa population of South Africa. 
- Evaluate the association between IL-1B polymorphism and severity 
of chronic periodontitis 
- Evaluate the association between the composite genotype and 
severity of chronic periodontitis in the Xhosa population of South 
Africa. 
 
3.3 – NULL HYPOTHESIS 
There is no significant association between the IL-1 composite 
genotype and the severity of chronic periodontitis. 
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CHAPTER 4 
MATERIALS & METHODS 
 
4.1- STUDY DESIGN AND PREPARATION  
The study design was a 1:1 matched case-control study, and the study 
population was of patients attending at department of oral medicine 
and periodontics at Mitchell’s Plain Oral Health Center, Gugulethu 
dental clinic and Tygerberg Hospital. 
Although the researcher was aiming at maximum 50 subjects at the 
beginning of the research (as a pilot study), the size of the sample was 
doubled to achieve better statistical analysis after power calculation 
(p-value was set at <0.05 for significance, to have 95% confidence 
interval and 80% power), and a total of 108 patients were finally 
enrolled in the study.  
 Subjects included were 35-60 years of age, free of systemic disease, 
non smokers, with no history or evident signs of aggressive 
periodontitis, and both parents and grand parents of the Xhosa 
population. The Xhosas are part of the southern Nguni African growth 
and they are well established population in the Eastern Cape and 
Western Cape provinces in South Africa.84 Subjects had no first degree 
siblingship to other subjects.  
Patients with moderate to severe chronic periodontitis were regarded 
as investigation subjects (case group). 
Patients with no or mild chronic periodontitis were regarded as 
controls. 
All subjects were screened for the degree of periodontal disease in 
each of three parameters. These parameters were pocket depth, 
recession and clinical attachment loss (CAL). In addition, a medical 
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and dental history of each subject was obtained including specific 
questions on family history of diabetes, cardiovascular disease as well 
as whether or not they were smokers. All subjects were of low to 
middle socioeconomic class. Subjects who agreed to participate in the 
study signed a consent form (In the Xhosa language).  
The protocol was approved by ethical and research committee of the 
University of the Western Cape, Cape Town, South Africa and 
participation in the study was on voluntary basis. 
All statistical tests were done using commercial software: SPSS 14.0 
(SPSS corp.2005). 
4.2 CLINICAL EXAMINATION:  
In order to determine periodontal disease status, each patient 
underwent an examination by a calibrated examiner, including a full 
mouth measurement of probing depth (PD) and recession (R). All 
clinical assessments were performed by one calibrated examiner who 
started by examining few patients randomly scoring more than 80% 
intra-examiner reproducibility. Smears of the patients were obtained in 
accordance with the instructions of the genetic laboratory as a training 
phase before proceeding into sample collection. 
Probing depth was defined as the distance between the gingival 
margin and the bottom of the probeable pocket to the nearest whole 
mm.21 
Location of the gingival margin was considered as the distance 
between the cementoenamel junction (CEJ) and the gingival margin 
recorded to the nearest whole mm. This measure was given a positive 
sign in case of gingival recession and a negative sign when the gingival 
margin was located coronal to the CEJ. 21 
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The algebraic sum of the above 2 parameters was used to compute 
the clinical attachment level. Modified Plaque index, and modified 
Gingival index were used to denote the gingival health and oral 
hygiene status of the patients.84 
Plaque was recorded without any use of disclosing agents. 
Bleeding on probing was also recorde and was deemed positive if it 
occurred within 15 seconds after the assessment of probing depth.  
The number of lost teeth was recorded by the examiner in cases and 
controls. The minimum number of remaining teeth for the subject to 
be included in the study was 14 teeth.  
All clinical variables were calculated on six surfaces (distobuccal, 
buccal, mesiobuccal, mesiolingual, lingual and distolingual) on each 
tooth (excluding third molars) for up to 168 sites. The Williams® 
probe was used for clinical examination. 
Chronic periodontitis was defined by the history of disease status 
rather than active signs and symptoms.  
Moderate to severe disease was defined as patients presenting with 
mean loss of attachment of 2.5mm or loss of clinical attachment (CAL) 
of 3mm or above in 7 sites.4,7 
Panoramic radiographs were only adjunctive aids in diagnosis. Severe 
disease was defined as the presentation with 50% bone loss on 
radiographs, in 7 interproximal sites, with a total mouth mean bone 
loss greater than 30%.4, 7 
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4.3-DETERMINATION OF INTERLEUKIN-1 
POLYMORPHISMS 
 In order to take a buccal smear, candidate subjects should not have 
eaten for about one hour before collection of the sample, and for 
females lipsticks were to be avoided. Commercial polyester tipped 
applicators (sterile Dacron®) were used to collect the samples. Two 
buccal smears were obtained from each patient, by rubbing the buccal 
mucosa on the right and left side, for at least 30 seconds as suggested 
by the manufacturer. They were coded for identification purposes, 
stored in special sealed bags to avoid sun and temperature, and then 
sent to the laboratory for molecular analysis (Figure 4.1).               
The laboratory personnel responsible for genotyping did not know the 
clinical status or identity of the patient. 
DNA was extracted by GeneCare extraction kit at GeneCare Molecular 
Genetics private laboratory and it was stored there for future analysis. 
The extraction procedure was as follows: 
In short, two 2.0 ml microtubes were labeled per sample. The 
applicator tip of the buccal swab was inserted into a labeled 2.0 ml 
microtube and the handle was broken off. 400ul PBS was added and 
mixed on vortex for 20s, and then the applicator tip was shaken in PBS 
for 20 min (Figure 4.2). 
800ul cold reagent C-A was pippetted into a labeled 1.5ml microtube 
and 300Ul of the PBS-cell suspension was added and inverted several 
times to mix. The mixture was incubated at room temperature for 2 
min. The mixture then was centrifuged at 14000 rpm for 60s. The cells 
formed a pellet as supernatant (Figure 4.3) which was removed and 
50ul of reagent C-B was added and mixed by continuous pippitting. 
The new mix was incubated in a water bath at 80 C for 15 min. 5ul 
reagent C-C was added and mixed and then placed on a shaker for 10 
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min. In this way, the DNA was extracted and stored at -20° for future 
PCR reactions. 
 
The DNA concentration for each sample was measured using 
NanoDrop® ND-1000 spectrophotometer (NanoDrop technologies, 
USA) (Figure 4.4) and the results were used in order to calculate the 
volume of DNA to be added to the reaction mix of the PCR (Figure 
4.5). 
 
Detecting the IL-1A polymorphisms: 
The DNA was isolated and target sequences were then amplified using 
the polymerase chain reaction (PCR). Oligonucleotide DNA primers 
that target the specific polymorphic DNA region within the genes of 
interest were determined so that in the PCR reaction amplification of 
the target sequences was achieved.  
For IL-1A the primer sequence was as follows (Inqaba biotech, SA): 
 
Forward: 5' ACTAGACTGTGTATATCATCTGTGTT 3' 
Reverse: 5' GCTCGAATTATACTTTGATTGAGGG 3' 
 Cycling was carried out for 1 cycle at 95°C for 1 minute,  
                  35 cycles each at 94°C for 1 minute,  
                                        65°C for 1 minute,  
                                        72°C for 2 minutes,  
                   and 1 cycle at 72°C for 5 minutes.  
The DNA sequences were amplified and analyzed using Real-time PCR 
for IL-1a.  
The basic theory behind Real-time polymerase chain reaction is that 
the more abundant a particular DNA is in a sample, the earlier it will 
be detected during repeated cycles of amplification. Typically, 
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amplification of a given DNA sequence over time follows a curve, with 
an initial flat-phase, followed by an exponential phase. Finally, as the 
experiment reagents are used up, DNA synthesis slows and the 
exponential curve flattens into a plateau.     
In Real-time PCR There is continuous collection of fluorescent signal 
from polymerase chain reaction throughout cycles. 
Rapid-cycle PCR was used (LightCycler®, Roche)(Figure 4.6), which is 
a powerful technique for nucleic acid amplification and analysis. 
Samples amplified by rapid-cycle PCR are immediately analyzed by 
melting curve analysis in the same instrument. In the presence of 
fluorescent hybridization probes, melting curves provide dynamic dot 
blots for fine sequence analysis, including SNPs (Figure 4.7). In 
melting curve (dissociation) analysis: Every piece of DNA has a 
melting point (Tm) at which temperature 50% of the DNA is single 
stranded. The temperature depends on the length of the DNA, 
sequence order and the G:C content. When DNA-binding dyes are 
used, as the fragment is heated, a sudden decrease in fluorescence is 
detected when Tm is reached (due to dissociation of DNA strands and 
release of the dye). This point is determined from the inflection point 
of the melting curve (Figure 4.8) or the melting peak of the derivative 
plot (Figure 4.9) (Derivative plot is the negative first-derivative of the 
melting curve and it is easier to be interpreted). The same analysis 
can be performed when hybridization probes are used as they keep 
intact after PCR. Mismatch between a hybridization probe and the 
target results in a lower Tm. Melting curve analysis can be used in 
known and unknown (new) mutation analysis as a new mutation will 
create an additional peak or change the peak area. 
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Detecting the IL-1B polymorphisms: 
The restriction fragment length polymorphisms and gel electrophoresis 
was used for IL-1b to determine the genetic polymorphisms present in 
the amplified sequences and thereby provide a genetic polymorphism 
profile of the patient. 
The PCR set up for IL-1B (+3954) was as follows: 
Forward primer: 5' - CTC AGG TGT CCT CGA AGA AAT CAA - 3'.  
Reverse primer: 5' - GCT TTT TTG CTG TGA GTC CCG - 3'.  
After optimization of the reaction the following reaction mixture was 
used: DNA (100 ng/ul), BSA (0.4 ng/ul): 2ul, MgCl2 (2mM): 2ul, 
reaction buffer to a final concentration (1X): 5ul, Taq polymerase 
(Biotaq, Bioline limited, UK)(1.5 units): 0.3ul, dNTPs (100uM): 2.5ul, 
F’ primer (50 pM): 1ul, R’ primer (Inqaba Biotech, SA)(50 pM): 1ul, 
and distilled water to get finally 50ul reaction mix. 
Cycling was carried out for 1 cycle at 95°C for 2 minutes, 38 cycles for 
1 minute each at 94°C, 53°C and 72°C, and 1 cycle at 72°C for 8 
minutes in Eppendorf thermal cycler.                                                              
The resulting amplicon of 194 base pairs were resolved on 2% agarose 
gel alongside a 100bp ladder (Fermentas, SA) on 1X TBE solution. It 
was visualized via Ethidium bromide staining (1ul/75 ml of agarose 
gel), then it was viewed under UV-transilluminator (UVITEC). 
The resulting PCR products were digested overnight at 370C with each 
reaction containing 5 µl of the respective PCR products, 10 Units Taq I 
and 1x reaction buffer. Restriction products were resolved on a 8% 
polyacrylamide gel and yielded either two cut fragments of 85 + 97 bp 
(in allele1[C]) or a single uncut intact 182 bp fragment (allele 2[T] 
when the subject is homozygous) or both cut and uncut fragments 
when the patient is heterozygous (allele 2 on one copy of the 
chromosomes).For IL-1a, allele identification was visual at the time of 
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PCR, while for IL-1b it was by the size of fragments after restriction 
digestion and separation in polyacrylamide gel. 
 
 
                                                                                                                                     
 
 
 
 
 
 
 
 
 
 
 
 
Figures 4.1: Dacron applicators, 4.2: Collection of cells from smears, 4.3: Pellet 
formation, 4.4: Nanodrop spectrophotometer, 4.5: DNA concentration and 4.6: 
Roche Light cycler PCR machine. 
Fig 4.1 Fig 4.2 
Fig 4.3 Fig 4.4 
Fig 4.5 Fig 4.6 
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Figure 4.7 Programming of the PCR machine with the required cycles   
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Figure 4.8 Inflection point of the melting curve coincides with the melting 
temperature (Tm). 
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Figure 4.9 Derivative plot is the negative first-derivative of the melting curve; the 
peak coincides with (Tm). 
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CHAPTER 5 
RESULTS: 
 
5.1- OVERVIEW: 
 
The main findings of this study can be summarized as follows: 
No difference in the prevalence of the positive composite IL-1 
genotype was observed between a group of periodontitis patients and 
a control group of age and gender matched periodontally healthy to 
mild subjects; and the components of this hypothetical genotype were 
analyzed separately. 
When Interleukin-1 B gene polymorphism was studied individually no 
significant difference was observed between cases and controls. A 
positive association was observed, however, between the severity of 
periodontal disease and the presence of the gene polymorphism on IL-
1A.  
 
In a separate analysis the potential causative factors were run in a 
multivariate logistic regression model. Age, gender, PI, GI and number 
of lost teeth were not significantly associated factors with the severity 
of periodontal disease. IL-1A polymorphism was significantly 
associated with severity of periodontitis when the regression model 
was adjusted for confounding factors. 
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5.2- DEMOGRAPHIC AND DESCRIPTIVE CLINICAL 
RESULTS: 
A total of 99 samples were successfully analyzed at the end of the 
study (table 5.1), 49 were for cases and 50 were for controls. Females 
presented more than males for treatment, and out of the 99 subjects 
63 (63.6%) were females and 36 (36.4%) were males (table 5.2). 
Females presented more often in both cases and controls taken 
individually as well, but they had the same percentage among cases 
and controls (table 5.3). 
  
  Frequency Percent 
  
Healthy to mild (controls) 
50 50.5 
  
Moderate to severe (cases) 
49 49.5 
  
Total 
99 100.0 
Table 5.1 The distribution of the sample into cases and controls 
 
 
  Frequency Percent 
  
Male 36 36.4 
  
Female 63 63.6 
  
Total 99 100.0 
Table 5.2 The distribution of gender in the sample 
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Gender 
Total Male Female 
 
Periodontal 
status 
Healthy to mild Count 18 32 50 
% within Periodontal 
status 
36.0% 64.0% 100.0% 
Moderate to 
severe 
Count 18 31 49 
% within Periodontal 
status 
36.7% 63.3% 100.0% 
Total Count 36 63 99 
% within Periodontal 
status 
36.4% 63.6% 100.0% 
Table 5.3 The distribution of gender among cases and controls 
 
The mean age of the study population was 46 ± 9 in cases and 44 ± 8 
in controls measured in whole years. Due to the reported higher mean 
age in cases than in controls a statistical test was necessary to assess 
if the age is related to periodontal status. 
Using distribution charts it was found that data in cases and controls 
were non-parametric, so the Mann-Whitney Test was used and the P-
value was 0.251. That meant that there was no significant difference 
in the two groups with regard to age. 
The mean clinical attachment loss was 2.5 ± 0.5 in cases and 0.5 ± 
0.4 in controls measured in millimeters. This difference can be 
attributed to the fact that the clinical attachment loss defines the 
periodontal disease status and varies considerably between cases and 
controls (See 4.2). Data were non-parametric and Mann-Whitney test 
showed a significant difference between cases and controls (p= 0.00)  
With regard to the number of lost teeth, the mean value was 4.4± 3.1 
in cases and 4.0± 2.9 in controls. The p-value was 0.522 for Mann-
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Whitney test and there was no significant difference in the two groups 
with regard to the lost teeth. 
The PI and GI were tested both in cases and controls, and it was found 
that the mean PI in cases was 1.6± 0.7 and in controls 1.0 ± 0.7 while 
for the GI the mean was 1.7± 0.7 in cases and 1± 0.8 in controls.  
Data were non-parametric both for PI and GI and Mann-Whitney tests 
showed that the differences were highly significant between cases and 
controls with a p-value of 0.00 for both PI and GI.  
 
Table 5.4 summarizes the distribution of mean age, clinical attachment 
loss, number of lost teeth, plaque index and gingival index among 
cases and contols. 
 
 
 
  
Periodontal status 
Healthy to mild Moderate to severe 
Mean Std Deviation Mean Std Deviation 
Age (in years) 44 8 46 9 
Clinical attachment loss 
(in mm) 
0.5 0.4 2.5 0.5 
Tooth loss (Number of 
lost teeth) 4.0 2.9 4.4 3.1 
Plaque index (PI) 1.0 0.7 1.6 0.7 
Gingival index (GI) 1.0 0.8 1.7 0.7 
 
Table 5.4 Distribution of some demographic and descriptive clinical findings in cases 
and contols 
 
 
 
 
 
 
 
 
 52
 
6040
Age (in years)
25
20
15
10
5
0
Fr
eq
ue
nc
y
Mean =45.13
Std. Dev. =8.355
N =99
 
6040
Age (in years)
12.5
10.0
7.5
5.0
2.5
0.0
Fr
eq
ue
nc
y
12.5
10.0
7.5
5.0
2.5
0.0
Healthy to m
ild
M
oderate to severe Periodontal status
 
 
Figure 5.1 Distribution of Age in the study population and in cases and controls  
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Figure 5.2 Distribution of CAL in the study population and in cases and controls  
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Figure 5.3 Distribution of Tooth loss in the study population and in cases and controls  
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Figure 5.4 Distribution of PI in the study population and in cases and controls  
 
 
 
 
 56
3.02.52.01.51.00.50.0
Gingival index
12.5
10.0
7.5
5.0
2.5
0.0
Fr
eq
ue
nc
y
Mean =1.346
Std. Dev. =0.8147
N =99
 
 
3.02.52.01.51.00.50.0
Gingival index
10
8
6
4
2
0
Fr
eq
ue
nc
y
10
8
6
4
2
0
Healthy to m
ild
M
oderate to severe Periodontal status
 
Figure 5.5 Distribution of GI in the study population and in cases and controls  
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5.3- INTERLEUKIN-1A AND THE PERIODONTAL STATUS: 
The prevalence of allele 2 of IL-1A was 34% in the study population, 
composed of 28% who were heterozygous and 6% who were 
homozygous for the allele. Looking at the distribution between cases 
and controls it was found that in cases the allele 2 occurred more 
frequently than in the controls (prevalence in cases was 53% allele 1, 
38.8% allele 2 heterozygous, and 8.2% allele 2 homozygous, while in 
controls allele 1 prevalence was 78.0% , allele 2 heterozygous was 
18.0% and allele 2 homozygous was 4.0%) (Table 5.5). 
  
  
  
     IL-1A polymorphisms 
Total 
  Allele 1 
Allele 2 
Heterozygous 
Allele 2 
Homozygous 
Periodontal 
status 
  
  
  
Healthy to 
mild 
  
Count 39 9 2 50 
% within 
Periodontal 
status 
78.0% 18.0% 4.0% 100.0% 
Moderate to 
severe 
  
Count 26 19 4 49 
% within 
Periodontal 
status 
53.1% 38.8% 8.2% 100.0% 
Total 
  
Count 65 28 6 99 
% within 
Periodontal 
status 
65.7% 28.3% 6.1% 100.0% 
Table 5.5 The distribution of IL-1A alleles in cases and controls 
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 Homozygous 
Allele 1 
Heterozygous Homozygous 
Allele 2 
Allele 1 Allele 2 Total # 
Alleles 
Cases 26  
(0.531) 
19  
(0.388) 
4  
(0.082) 
71  
(0.724) 
27  
(0.276) 
98 
Controls 39  
(0.78) 
9  
(0.18) 
2  
(0.04) 
87 
(0.87) 
13 
(0.13) 
100 
Table 5.6 Genotype and Allele frequencies for the IL-1A polymorphism in cases and 
controls (Frequencies are given in brackets). 
 
The genotypes in Table 5.6 have been examined for adherence to 
Hardy Weinberg distribution and both cases (p=0.98) and controls 
(p=0.352) do not deviate from Hardy Weinberg equilibrium. 
 
It was noted that the cells were low in number in some categories 
which would compromise the accuracy of the proposed statistical tests 
for association of the periodontal status with the occurrence of allele 2 
polymorphism. 
In order to reduce the influence of very low sample numbers the data 
was examined with the numbers for the homozygous Allele 2 
individuals recoded as combined with the heterozygous individuals 
(thus allowing a comparison of samples carrying allele 2 vs those not 
carrying allele 2)  The recalculated data with the “collapsed” genotype 
distributions are shown in Table 5.7 
Chi-squared test was used with one degree of freedom.  
The occurrence of allele 2 was significantly associated with the 
presence of the severe form of periodontal disease when the cells were 
collapsed (p-value was 0.009). 
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IL-1A 
polymorphisms 
Total Allele 1 Allele 2 
Periodontal 
status 
Healthy to mild Count 39 11 50 
% within Periodontal 
status 
78.0% 22.0% 100.0% 
Moderate to 
severe 
Count 26 23 49 
% within Periodontal 
status 
53.1% 46.9% 100.0% 
               
                  Total 
Count 65 34 99 
% within Periodontal 
status 
65.7% 34.3% 100.0% 
Table 5.7 Distribution of IL-1A alleles among cases and controls                                
(Allele 2 homozygous was collapsed with heterozygous) 
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Figure 5.6 The distribution of IL-1A alleles among cases and controls 
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5.4- INTERLEKIN-1B POLYMORPHISMS AND THE 
PERIODONTAL STATUS: 
 
In order to calculate the prevalence of IL-1B- allele 2 polymorphism, 
40 samples were run as a pilot, consisting of 19 cases and 21 controls. 
The allele 2 occurrence was very low as it occurred only in 10% as 
heterozygous and 5% as homozygous while 85% of the sample had 
allele 1. Also, the difference in occurrence of allele 2 between cases 
and controls was minor: as in the case group the prevalence of allele 2 
heterozygous was 10.5% and the homozygous was 5.3% while in the 
controls group the prevalence of allele 2 heterozygous was 9.5% and 
the homozygous was 4.8% (table. 5.8) 
 
  
           IL-1B polymorphisms 
Total 
  
Allele 
1 
Allele 2 
(Heterozygous) 
Allele 2 
(Homozygous) 
Periodontal 
status 
  
  
  
Healthy to 
mild 
  
Count 18 2 1 21 
% within 
Periodontal status 
85.7% 9.5% 4.8% 100.0% 
Moderate to 
severe 
  
Count 16 2 1 19 
% within 
Periodontal status 
84.2% 10.5% 5.3% 100.0% 
 
            Total 
Count 
34 4 2 40 
  % within 
Periodontal status 
85.0% 10.0% 5.0% 100.0% 
Table 5.8 The distribution of IL-1B alleles among cases and controls 
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 Homozygous 
Allele 1 
Heterozygous Homozygous 
Allele 2 
Allele 1 Allele 2 Total # 
Alleles 
Cases 16 
(0.842) 
2 
(0.105) 
1 
(0.053) 
34  
(0.89) 
4 
(0.11) 
38 
Controls 18 
(0.857) 
2 
(0.095) 
1 
(0.048) 
38 
(0.90) 
4 
(0.01) 
42 
Table 5.9 Genotype and Allele frequencies for the IL-1B polymorphism in cases and controls (Frequencies 
are given in brackets). 
 
 
The genotypes in Table 5.9 have been examined for adherence to 
Hardy Weinberg distribution and both cases (p=0.157) and controls 
(p=0.122) do not deviate from Hardy Weinberg equilibrium. 
 
As was the case in IL-1A, the tables in IL-1B had cells with very low 
numbers and the tables had to be modified accordingly, in order to 
test for the association of the periodontal status with the occurrence of 
allele 2 polymorphisms accurately (Table 5.10). 
In order to reduce the influence of very low numbers of samples the 
data was examined with the numbers for the homozygous Allele 2 
individuals recoded as combined with the heterozygous individuals 
(thus allowing a comparison of samples carrying allele 2 vs those not 
carrying allele 2). The recalculated data with the “collapsed” genotype 
distributions are shown in Table 5.10. 
 
It was found that the occurrence of allele 2 was not significantly 
associated with the presence of the severe form of periodontal 
disease.  
The Fischer exact test was used and the p-value was 0.619 upon 
merging of cells; that is not significant. 
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IL-1B polymorphisms 
Total Allele 1 Allele 2 
Periodontal 
status 
Healthy to mild Count 18 3 21 
% within Periodontal 
status 
85.7% 14.3% 100.0% 
Moderate to 
severe 
Count 16 3 19 
% within Periodontal 
status 
84.2% 15.8% 100.0% 
Total Count 34 6 40 
% within Periodontal 
status 
85.0% 15.0% 100.0% 
Table 5.10 Distribution of IL-1B alleles among cases and controls                     
(Allele 2 homozygous was collapsed with heterozygous) 
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Figure 5.7 The distribution of IL-1B alleles among cases and controls 
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5.5- LOGISTIC REGRESSION MODEL: 
 
In order to evaluate the effect of all potential contributing factors on 
the periodontal status, a multiple logistic regression analysis was run. 
The effect of IL-1A allele2 (collapsed) was tested in the presence of 
other factors like gender, age, PI and GI, and it was found that the IL-
1A polymorphism had a significant effect on the periodontal disease 
status (p-value= 0.025).  
On the other hand, some factors which had a significant effect at the 
univariate association models (like PI and GI) were not significantly 
associated with the disease status in the presence of other factors.  
 
  
 
  B S.E. Wald df Sig. Exp(B) 
Gender .231 .476 .237 1 .627 1.260 
  
Age 
.036 .027 1.725 1 .189 1.036 
  
PI 
1.348 .992 1.846 1 .174 3.850 
  
GI 
-.226 .942 .057 1 .811 .798 
  
IL1A(collapse) 
-1.104 .494 4.990 1 .025 .332 
  
Constant 
 
-2.433 1.365 3.178 1 .075 .088 
Table 5.11 Variables entered on logistic regression model: Gender, Age, PI, GI and 
IL1A collapse. 
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CHAPTER 6 
DISCUSSION 
6.1 – INTRODUCTION 
It is generally agreed that bacteria are the initiators of periodontitis, 
but there is increasing evidence to suggest that host factors, such as 
diabetes, smoking, and genetic influences contribute to the severity 
of destruction and thereby affect the clinical presentation and  
distribution of lesions.3 Risk factors can be understood as aspects of 
personal behavior or lifestyle, environmental exposure, inborn or 
inherited characteristics, which are epidemiologically known to be 
associated with a health-related condition. 
The multifactorial aetiology of periodontitis is similar to many 
common diseases involving multiple factors that together determine 
the clinical presentation of the disease in a specific individual.3 
Environmental and acquired risk factors affect the onset, rate of 
progression and can control the severity of periodontal disease as well 
as the response to therapy. Hence widespread more advanced disease 
occurs primarily in a fraction of the population.10 
 
Genetic factors play an important role in determining the actual 
clinical presentation of periodontitis as evidenced by studies of 
twins, studies of aggressive periodontitis and epidemiological 
studies of the natural history of periodontitis.11,12 It has been 
estimated by some investigators that less than 20% of the variability 
in periodontal disease expression can be explained by the quantity of 
specific bacteria found in disease associated plaque.4 These findings 
can explain the clinical observation that widespread advanced 
disease is not always associated with large amounts of plaque. 
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Specific bacteria initiate the inflammatory state in periodontitis. As the 
IL-1 polymorphism is involved in immuno-inflammatory processes, the 
clinical effects of this genetic factor depend on the presence of 
bacteria to initiate the inflammation. Although the risk factor may not 
be a proven cause of a particular disease, its presence implies an 
increase in the probability of the disease occurring, and not all patients 
with this genetic factor are therefore prone to severe periodontitis. It 
can be expected that removing the bacteria would decrease the 
effect of other risk factors such as the IL-1 genotype. In this study 
the indicators of bacterial challenge and oral hygiene level like the 
Plaque Index and Gingival Index were assessed.    
All subjects selected were free of systemic diseases to reduce the 
effect of a well-known confounding factor on periodontal disease. 
A history of smoking is considered to be an important risk factor 
for periodontal disease and this effect is dose dependent.36,37 
Previous investigations17,20,24 have shown that individuals smoking 
>10 cigarettes per day (one-half pack) have an increased disease 
severity and a less favorable response to therapy.37 Importantly, the 
IL-1 polymorphism was found to have a significant effect on 
attachment loss in non-smoking patients.7  
This study excluded smokers and persons who had been smokers in 
the previous 5 years in order to reduce the cumulative effect of 
smoking on periodontal disease.  
 
In finding a relationship between the putative risk factor and 
periodontitis, it is important that the association should be temporal, 
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consistent, strong and makes some biologic sense, though those 
elements are interrelated and can not be studied separately. 
As periodontal disease generally progresses slowly, persons studied 
over a long period may be exposed to multiple potential risk factors, 
making determination of a cause–effect relationship more difficult. 
In the present study patients included were of ages between 35-60 
year, in an attempt to reduce the range of the age as possible, as age 
could be a confounding factor to the disease. They were also chosen to 
ensure that they presented with the chronic (adult) periodontitis rather 
than the aggressive (early onset) types of disease. 
Consistency is the repeated demonstration, by different investigators, 
of an association between exposure to a putative cause (e.g., genetic 
factors) and the outcome of interest (e.g., periodontal attachment 
loss). Studies concerning the relationship between IL-1 polymorphisms 
and periodontal diseases were generally inconclusive, and this aspect 
will be discussed next section. 
The strength of the evidence is determined by the study design. 
Prospective studies are needed to calculate the probability of 
developing a disease. For example, if 30 of 100 patients who were 
genotype-positive developed periodontitis, then the risk of developing 
the disease could be calculated (30 percent chance of developing the 
disease). This type of calculation can be done only in prospective 
studies; it cannot be done in retrospective investigations in which 
patients are selected after they already had the disease. 
 The best evidence can be drawn from a randomized clinical trial, but it 
is not ethical to produce periodontal disease in some patients (cases) 
and not practical to ensure that others (controls) will not develop 
disease, and so the clinical trial could not be applied in this study.                 
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 In prospective cohort studies, a group of people with and without 
exposure to a suspected cause over time (e.g. a particular genetic 
polymorphism) are followed in order to determine who develops the 
disease of interest (e.g. chronic periodontal disease). Unfortunately, 
cohort studies are expensive and time consuming, and could not be 
used in this study. 
  
A case-control study examines people with the disease in question 
(e.g. chronic periodontal disease) and matches them with “controls” 
who are disease free to determine differences between the 2 groups in 
the rate of exposure to a potential cause (e.g. comparing the 2 groups 
for rates of the genetic polymorphism). Although results from this type 
of study are associated with a greater potential for bias than those 
from a cohort study or randomized trial, they are often the only 
evidence available.  
 
Furthermore, clinical examination of patients provided information 
about the cumulative disease history of the patient and based on the 
current information the patient's likelihood of future disease and 
expectation of response to therapy can be assessed, but it is not 
possible to read the future even with the presence of a risk factor.   
This study was a case-control study that consisted of 49 cases with 
moderate to severe periodontitis and 50 age and gender matched 
controls who were healthy or with mild periodontitis. 
  
The other element of interest is that there should be some reasonable 
biologic explanation for the putative cause to play a role in the 
outcome. This can be shown as IL-1 is a powerful regulator of the 
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inflammatory process and increased levels of IL-1 were associated 
with the immuno-pathology of the periodontitis.3, 4, 15,25,26,69 
 Interleukin-1 (especially IL-1b) is also known to be a critical 
determinant of bone and collagen destruction. IL-1 levels are 
higher in GCF from sites with periodontitis, 15 and recent findings 
indicated that specifically blocking both IL-1 and TNFα significantly 
reduced periodontal bone destruction in periodontitis, in spite of a 
heavy bacterial challenge.38 It is assumed, therefore, that the positive 
composite genotype does, in fact, translate into a phenotype of 
enhanced IL-1 production to a given bacterial challenge.15,17 
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6.2 – INTERLEUKIN-1 POLYMORPHISMS AND 
PERIODONTAL DISEASE STATUS 
To the best of knowledge, there has been no information published 
about the association of IL-1 polymorphisms and chronic 
periodontitis in any indigineous African population. However, there 
have been studies that investigated the early-onset type of periodontal 
diseases in African-American subjects. 13, 43  
In order to determine this association in the present study, the 
researcher had to assess first the prevalence of the IL-1α +4845 and 
IL-1β +3954 genetic polymorphisms in a population of African 
ancestry.The relationship between these polymorphisms to the 
periodontal disease status was subsequently assessed in these 
persons. 
 
The IL-1α +4845 polymorphism is reported to be in almost 
complete linkage disequilibrium (>99%) with the previously tested 
IL-1α-889 polymorphism, 18 and it is easier to be evaluated 
technically. 
In the first test, (IL-1A) real time PCR genotyping was done for 99 
unrelated subjects. In the healthy to mild periodontal disease group 
the prevalence of allele 2 IL-1α +4845 was 22%, while for allele 1 it 
was 78%. There was a significant difference in the prevalence of the 
IL-1α +4845 genotype in the case group where 46.9% had allele 2 
and 53.1% carried allele 1. This difference was significant when it was 
tested by logistic regression model with the presence of other factors 
such as age, PI and GI. 
However, in literature it is established that IL-1B is the more important 
polymorphism as related to periodontitis.6 
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Diehl and coworkers 43 reported that the IL-1β +3953 polymorphism 
was more significantly associated with early onset periodontitis 
than the IL-1α-889 polymorphism. In an African-American control 
population, the prevalence of the IL-1β +3954 was 73% (1,1), 26% 
(1,2), and 1% (2,2). This prevalence was similar to that observed 
in the early onset population examined, with 84% (1,1), 16% 
(1,2), and 0% (2,2).13 In our African control population, the 
prevalence of the IL-1β +3954 was 85.7% (1,1), 9.5% (1,2), and 
4.8% (2,2). This prevalence was similar to that observed in the 
moderate to severe periodontitis, cases group, with 84.2% (1,1), 
10% (1,2), and 5.3% (2,2). 
A case-control study comprising gingivitis patients, patients with 
advanced periodontal disease and control populations, 73 reported a 
significantly higher prevalence of allele 2 at IL-1B +3954 in the 
advanced periodontitis group when compared to the reference 
population (55% versus 26.7%). Another case-control study 
comprising 32 Caucasian adult periodontitis patients age- and gender 
matched with healthy controls, revealed a statistically significantly 
increased frequency of allele 2 at the IL-1B +3954 locus among 
patients with advanced periodontitis and subjects with mild or 
moderate disease; however, a comparison of the advanced disease 
group to the controls did not reveal a statistically significant different 
occurrence rate. 6 
 
On the contrary, the findings suggested that allele "1" of the IL-1β 
+3953 polymorphism is the most prevalent allele in the general 
African population of South Africa. The majority of cases and control 
population were homozygous for the IL-1β +3953 "1" allele (1/1 
genotype). 
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These findings highlighted the high prevalence of the ‘normal’ allele in 
the African population, as well as the resemblance to the results of the 
African-American population. 
 The fact that the genotype frequencies for IL-1A and IL-1B in both 
cases and controls do not deviate from Hardy Weinberg equilibrium 
shows that there is not selection bias in the groups studies.  The 
sample size in both cohorts is small and larger numbers of samples 
may change this result. 
 
The occurrence of the positive genotype found in this study is 
significantly lower than the 29.1% rate found in Northern European 
subjects of unknown periodontal status or the reported 36.3% 
prevalence in non-smoking periodontitis patients,  or as comparable to 
the 40.6% rate in Australians of essentially European heritage.4,22  
The concept of the composite genotype as a susceptibility factor for 
periodontitis was challenged in this study similar to previous studies 
that were done in non-Caucasian populations.8, 13 It was the IL-1B in 
particular which occurred in a low prevalence that made it difficult to 
draw any relationship between the proposed composite genotype and 
the periodontal disease status. 
It was concluded that this polymorphism alone does not carry 
significant risk for severe chronic periodontitis. 
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6.3 – CLINICAL APPLICATION 
It is relevant in the present study that 22% of the healthy or mild 
periodontitis patients had allele 2 at IL-1A. As is seen with some risk 
factors in other multifactorial diseases, the IL-1 genotype can be 
present without always being associated with clinical disease. On the 
other hand, the genotype positive patients who did not have 
periodontitis could possibly have controlled other factors that are 
necessary for disease, such as bacterial load. 
 
In periodontal therapy, there is great reliance on patient participation. 
Individuals that are at increased risk are advised to perform 
stringent plaque control methods, and frequent professional care 
may be an appropriate strategy to manage the increased risk to 
develop periodontitis. 
In general, the findings demonstrated that the IL-1 composite 
polymorphism is not related to the severity of periodontitis in 
subjects with disease. 
At the same time, it is important that knowledge of the IL-1 
genotype of a patient could be useful, if longitudinal data of 
disease progression or treatment outcomes reveal that 
genotype positive subjects have a poorer prognosis.  
A study where 42 patients were maintained over 14 years, 
found that IL-1 genotype-positive subjects had a 2.7 increased 
risk for tooth loss.72 Contrary to these findings, a study of 48 
patients scheduled for regular recall visits and followed-up for 
two years after non-surgical periodontal therapy, reported no 
differences in the survival rates of teeth or in the progression 
of attachment loss between genotype positive and negative 
subjects. 76  
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Additional data is needed to clarify these effects and it is 
recommended that a larger prospective project shall include 
persons of different ethnic backgrounds in South Africa. The 
objective of the study will be to provide longitudinal 
assessments in both cases and controls, and to determine the 
relative importance of the IL-1 genotype against other risk 
factors for disease progression as well as to identify new or 
different mutations in different ethnicities. 
In addition, in the future such information might be utilized to 
modify the patient’s risk and to guide prevention and therapy 
by identification of theses persons with higher risk to develop 
the disease in the future. 
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CHAPTER 7 
LIMITATIONS 
 
This study had several limitations, as related to the structure 
and design, time frames, technical aspects and availability of 
the resources. 
The study was case-control and not prospective in design, and 
having strict inclusion criteria the sample had to be selected 
out of more than thousand of patients screened. The primary 
researcher was foreign student and had to go to different areas 
in order to meet the specific population, which had a language 
unfamiliar to the researcher, who is not even an English 
speaker. Females presented more often than males in the 
clinics and in order to match cases and controls males were to 
be selected. The researcher did not have a clinical assistant 
due to financial constraints, and other than the full mouth 
clinical examination of the samples he had to occasionally 
undertake “routine” emergency treatment for patients whether 
they were included or not in the study. Those factors could 
have resulted in observer bias or selection bias in the clinical 
part of the study. 
The laboratory part was complicated twice by absence of 
researchers dedicated for this research and some results were 
unverified and were disregarded in the statistical part.  
 
The authorundertook did two tuition courses in molecular 
genetics, including his actual participation in DNA extraction 
from cells and performance of PCR and running the products 
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into gels.  He also attended beginner and intermediate courses 
in statistics with SPSS. It is relevant that the author was a 
dentist and so the literature used was mainly dental, and the 
scope of the study might be expected on this regard. 
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CHAPTER 8 
CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions drawn from the literature on the role of the 
positive composite IL-1 genotype, or the ability of specific 
alleles at the two investigated loci, to discriminate between 
subjects with and without of periodontal disease were 
inconclusive.  It should be noted, that the previous studies 
differed considerably in their methodology, therefore, direct 
comparisons are not readily feasible.  
 
However, with regard to the limitations, and based on the 
findings of this case-control study, to evaluate the prevalence 
and association of interleukin-1 polymorphisms among subjects 
with moderate to severe periodontal disease and age and 
gender matched controls non-smokers of the Xhosa population 
of South Africa, the following can be concluded: 
 
Screening of subjects for IL-1 gene polymorphisms in view of 
making assumptions on their risk for periodontal disease does 
not appear to be justified. However, the data clearly indicated 
a significant effect of Interleukin-1A on the severity of chronic 
periodontal disease. This association was kept both when the 
genotype was tested alone with the disease status and also 
when it was analyzed in the presence of other confounding 
factors. 
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It is important to note as well, that the cause-effect 
relationship of chronic diseases, such as periodontal disease, is 
not easy to prove.  
 
Thus, additional prospective studies that enroll a sufficient 
number of subjects are needed to investigate valid predictive 
rates of chronic periodontitis associated with a genotype-
positive test result. 
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. Appendix A: General definitions of the terms used in this thesis (See: 
www.geneclinics.org) 
Allele – one of several possible alternative forms of a given gene 
differing in DNA sequence assumed to arise by mutation and often 
affecting the function of a single product. Humans carry two sets of 
chromosomes, one from each parent. Single nucleotide polymorphisms 
may render two sets of equivalent genes different. 
Alternative splicing – the generation of multiple protein isoforms from 
a single gene via the splicing together of nonconsecutive exons during 
RNA processing of some but not all of RNA transcripts. Believed to be 
the mechanism involved with the high number of proteins produced 
from a smaller number of genes in humans. 
Autosome – chromosomes other than sex chromosomes. 
Autosomal dominant – Describes a trait or disorder in which the 
phenotype is expressed in those who have inherited only one copy of a 
particular gene mutation (heterozygotes); specifically refers to a gene 
on one of the 22 pairs of autosomes (non-sex chromosomes) 
 Autosomal recessive – Describes a trait or disorder requiring the 
presence of two copies of a gene mutation at a particular locus in 
order to express observable phenotype; specifically refers to genes on 
one of the 22 pairs of autosomes (non-sex chromosomes)  
Complementary DNA (cDNA) – the DNA sequence produced by the 
enzyme called reverse transcriptase from messenger RNA. Very 
frequently used in cloning experiments. 
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Chromosome – Physical structure consisting of a large DNA molecule 
organized into genes and supported by proteins called chromatin  
Cloning – An identical copy of a DNA sequence or entire gene; one or 
more cells derived from and identical to a single ancestor cell; to 
isolate a gene or specific sequence of DNA  
Dizygotic twin – fraternal twins as a result of fertilization of two 
separate eggs. They are no more similar genetically than are siblings. 
Exon – Coding sequence of DNA present in mature messenger RNA  
False-positive rate: A test result which indicates that an individual is 
affected and/or has a certain gene mutation when he or she is actually 
unaffected and/or does not have the mutation; i.e., a positive test 
result in a truly unaffected individual 
False-negative rate: A test result which indicates that an individual is 
unaffected and/or does not have a particular gene mutation when he 
or she is actually affected and/or does have a gene mutation; i.e., a 
negative test result in an affected individual 
 Frameshift mutation – A type of mutation as a result of an insertion or 
deletion of one or more nucleotides into a gene causing the coding 
regions to be read in the wrong frame. 
Gene – The basic unit of heredity, consisting of a segment of DNA 
arranged in a linear manner along a chromosome. A gene codes for a 
specific protein or segment of protein leading to a particular 
characteristic or function. 
Gene expression – the process involving use of the information in a 
gene via transcription and translation leading to production of a 
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protein affecting the phenotype of the organism determined by that 
gene. 
Genetic code – in RNA and DNA, the consecutive nucleotide triplets 
(codon) that specify the sequence of amino acids for protein synthesis 
(translation). 
Genetic screening: Large-scale testing of defined populations for a 
genetic disease or disease-causing gene. 
Genome – a term used to refer to all the genes carried by an individual 
or cell. 
Genotype – the genetic makeup of an organism or cell distinct from its 
expressed features or phenotype. 
Haplotype – the collection of one allele of each gene comprising the 
genotype. 
Homozygous – the presence of identical alleles of one or more specific 
genes (e.g. A/A). 
Heterozygous – the presence of differing alleles of one or more specific 
genes (e.g. A/B). 
Intron – the intervening (non-coding) portion of DNA or RNA that is 
removed during RNA processing. 
Isoforms – a protein with equivalent function and similar or identical 
sequence but derived from a different and usually tissue-specific gene. 
Ligand – any particular molecule that binds to another such as a 
hormone to its receptor. 
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Linkage: A greater association in inheritance of two or more non-allelic 
genes than is to be expected from independent assortment. Genes are 
linked because they reside in close proximity on the same 
chromosome. 
Linkage analysis: A method of determining the chromosomal location 
of a gene of interest. 
Linkage disequilibrium: The tendency of specific combinations of alleles 
at two or more linked loci to occur together on the same chromosome 
more frequently than would be expected by chance. 
Locus (plural loci) – the physical location a gene occupies within a 
chromosome or portion of genomic DNA. 
LOD (logarithm of the odds) score: Computation performed to 
evaluate support for/against a linkage hypothesis. Specifically, it is a 
common logarithm of the ratio of the likelihood of linkage at a specific 
recombination fraction to the likelihood of no linkage. 
Monozygotic twin – identical twins having identical sets of nuclear 
genes as a result of separation of blastomeres.  
Mutation – alteration of the genomic sequence compared to a 
reference state. Not all mutations have harmful events (silent 
mutation). 
Phenotype – the observable characteristics displayed by an organism 
as influenced by environmental factors and independent of the 
genotype of the organism. 
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Polymorphism – a region on the genome that varies between individual 
members of a population present in a significant number of individuals. 
Sequencing – the linear arrangement of nucleotides (in RNA or DNA) 
or amino acids (in protein). 
Segregation analysis: Method of assessing relative support between 
various hypothesized inheritance patterns for a trait of interest. 
Sensitivity of a genetic test: The proportion of cases that are correctly 
identified by the genetic test. 
Silent mutation – a mutation resulting in no noticeable change in the 
biological activity of the protein encoded by the affected gene. 
Single nucleotide polymorph (SNP) – a polymorphism caused by the 
change in a single nucleotide believed to be the most common genetic 
variation between individual humans. 
Signal transduction – the cascade of cellular events by which an 
extracellular signal such as a hormone or growth factor interacting 
with a receptor on the cell surface triggers an internally-directed 
response. This stepwise occurrence usually results in changes in gene 
expression in the nucleus. 
Single nucleotide polymorphism (SNP): A small genetic change or 
variation that can occur within a person’s DNA sequence. The genetic 
code is specified by the four nucleotide “letters” A: adenine; C: 
cytosine; T: thymine; and G: guanine. SNP variation occurs when a 
single nucleotide, such as an A, replaces (substitutes for) one of the 
other three nucleotide letters C, G, or T. 
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Specificity of a genetic test: The proportion of controls that are 
correctly identified by the genetic test. 
Splicing – the removal of introns from transcribed RNAs. The removal 
of exons results in the formation of ‘splice variants’ or ‘alternatively 
spliced’ protein isoforms allowing different proteins to be produced 
from the same initial RNA or gene. 
X-linked disease – a disease of genetic origin as a result of a mutation 
on the X-chromosome. 
Vector – common term for a carrier of and organism, DNA, RNA, or 
protein to be transferred from one organism to another. Examples 
include plasmids, viruses, and mosquitoes. 
Wild type – the non-mutated, naturally-occurring form of a gene. 
 Note: Ethidium Bromide (EtBr) is strongly mutagenic. Toxic effects of this 
chemical may be observed upon swallowing, inhalation or absorption through the 
skin. Gloves should be worn at all times when handling EtBr. 
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Appendix B: Charting sheets 
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      Appendix C: consent form English copy                               
                                
                               Consent Form 
Patient information sheets  
Prevalence of Interleukin –1 gene polymorphism and its 
association with periodontal status in the Xhosa population of 
South Africa                    
                       Researchers : Dr . Abu Saleh T 
                                              Prof. Stephen LXG 
                                    Faculty of Dentistry 
                           University of the Western Cape  
 
The purpose of this study is to determine the prevalence of the Interleukin-1 
composite genotype in individuals of the Xhosa population of South Africa , as 
well as  to evaluate if there is an association between the composite genotype 
and the severity of periodontal disease. People who will participate in this study 
will be examined for periodontal disease, and then a buccal smear will be 
obtained. Samples will be given codes and the DNA in the sample will be 
analyzed in the laboratory of molecular genetics for the presence of IL-1 
polymorphisms, without knowledge of patient names or records. 
Patients will be treated or referred for treatment, and they have the right to 
withdraw from the study at any stage without affecting their treatment or referral 
procedure .The results of this study will help determine which people are of 
higher risk to develop severe periodontal disease.  
The information obtained in this study will be treated with utmost confidentiality 
and the names of the participants will not be divulged for any other purposes. 
For any further information please contact: 
Dr Abu Saleh ,Tareq  
E-mail: 2558431@uwc.ac.za 
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Consent  
I have read the information, asked questions and received answers concerning 
areas that were unclear and I willingly agree to participate in this study. My 
participation is completely voluntary. I may withdraw at anytime. I will not have 
waived any of my legal rights by signing this consent form. Upon signing this 
form, I will receive a copy of the entire consent.  
…………………                                ………………         ……………… 
Participant name                              Signature                Date  
…………………                                ……………….         ……………… 
Witness name                                    Signature              Date   
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                     Appendix D: consent form Xhosa copy 
 
I- phepha le Mvume  
 
Ukuvela kwe interleukin-imeko yokuzala isifo ekuthiwa yi 
polymorphism - nebanga le sisifo sama zinyo neentsini kubantu 
abangama Xhosa kum Zantsi Africa  
Lomsebensi wenziwa ngu gqira  Abu Saleh T  
                                   no Proffesor Stephen LX    
Kwiziko lemfundiso enomsila ibizwa ngokuba yi universityof the 
Western Cape . 
Imbanghe yale mfuniso yeyo kwenza ukukwazi okuba isifo 
samazinyo neetsi zibonakala kanjani kubantu ababizwa ngokuba 
ngama Xhosa emzantsi Africa , nokoku kwazi ukuba ikhona 
indibaniso yokuvela kwezisifo nububanzi kwavo  
Abantu abaza kuthathela inxaxeba kweli bando baya kufumana 
ibuccal smear , lento yenziwa ngokusulwa  kwamazinyo neentsi 
nge cephe elithambilyo lithunyelwe e laboratory . Akukho 
mfuneko le gama lomtu .  
Isigulana siyaku nyangwa , oko unayo imvume yokuba uthi 
akufuni oku thatha inxaxeba kulomvange .  
Olwaziso liyimfihlelo kwabanye abantu. Ndiyabulela .  
   
Dr Abu Saleh  
E-mail 2558431@uwc.ac.za 
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Imvume . 
Ndiyifundile ulwaziso, ndibuze imibuzo, kwaze ndafumana 
iimpendulo, kwaze kwindawo ebendigaziqondi ndizichazelwe . 
Ndiya yazi ukuba ndigayeka nokuba kunini na . 
 
Igama lakho         Ubhale                Imini 
……………         ……….               ………… 
 
Ingqina                    Ubhale                Imini 
 
………….            …………            …………… 
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                             Appendix E: Statistical Results 
 
 
 Ranks 
 
  Periodontal status N Mean Rank Sum of Ranks
Age (in years) Healthy to mild 50 46.73 2336.50
Moderate to severe 49 53.34 2613.50
Total 99   
 
 
 Test Statistics(a) 
 
  Age (in years)
Mann-Whitney U 1061.500
Wilcoxon W 2336.500
Z -1.147
Asymp. Sig. (2-
tailed) .251
a  Grouping Variable: Periodontal status 
 
 
 
 
Ranks 
 
  Periodontal status N Mean Rank Sum of Ranks 
Clinical attachment 
loss 
Healthy to mild 50 25.50 1275.00 
Moderate to severe 49 75.00 3675.00 
Total 99    
 
 
 Test Statistics (a) 
 
  
Clinical 
attachment loss
Mann-Whitney U .000
Wilcoxon W 1275.000
Z -8.584
Asymp. Sig. (2-
tailed) .000
a  Grouping Variable: Periodontal status 
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 Ranks 
 
  Periodontal status N Mean Rank Sum of Ranks 
Tooth loss (Number 
of lost teeth) 
Healthy to mild 50 48.18 2409.00 
Moderate to severe 49 51.86 2541.00 
Total 99    
 
 
 Test Statistics(a) 
 
  
Tooth loss 
(Number of 
lost teeth) 
Mann-Whitney U 1134.000 
Wilcoxon W 2409.000 
Z -.640 
Asymp. Sig. (2-
tailed) .522 
a  Grouping Variable: Periodontal status 
 
 
 
 
 
 Ranks 
 
  Periodontal status N Mean Rank Sum of Ranks
Plaque 
index 
Healthy to mild 50 38.94 1947.00
Moderate to severe 49 61.29 3003.00
Total 99   
 
 
 Test Statistics(a) 
 
  
Plaque 
index 
Mann-Whitney U 672.000 
Wilcoxon W 1947.000 
Z -3.877 
Asymp. Sig. (2-
tailed) .000 
a  Grouping Variable: Periodontal status 
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 Ranks 
 
  Periodontal status N Mean Rank Sum of Ranks
Gingival 
index 
Healthy to mild 50 39.18 1959.00
Moderate to severe 49 61.04 2991.00
Total 99   
 
 
 Test Statistics(a) 
 
  
Gingival 
index 
Mann-Whitney U 684.000
Wilcoxon W 1959.000
Z -3.795
Asymp. Sig. (2-
tailed) .000
a  Grouping Variable: Periodontal status 
 
 
 
 
 
  
Periodontal status 
Healthy to mild Moderate to severe 
Mean Std Deviation Mean Std Deviation 
Age (in years) 44 8 46 9
Clinical attachment loss .5 .4 2.5 .5
Tooth loss (Number of 
lost teeth) 4.0 2.9 4.4 3.1
Plaque index 1.0 .7 1.6 .7
Gingival index 1.0 .8 1.7 .7
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IL-1* periodontal status 
 Crosstab 
 
  
IL-1A 
Total Allele 1 
Allele 2 
(Heterozygous) 
Allele 2 
(Homozygous) 
Periodontal 
status 
Healthy to mild Count 39 9 2 50
% within Periodontal status 78.0% 18.0% 4.0% 100.0%
Moderate to severe Count 26 19 4 49
% within Periodontal status 53.1% 38.8% 8.2% 100.0%
Total Count 65 28 6 99
% within Periodontal status 65.7% 28.3% 6.1% 100.0%
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 6.829(a) 2 .033
Likelihood Ratio 6.939 2 .031
Linear-by-Linear 
Association 5.731 1 .017
N of Valid Cases 
99   
a  2 cells (33.3%) have expected count less than 5. The minimum expected count is 2.97. 
 
 
Periodontal status * IL-1B 
 
 Crosstab 
 
  
IL-1B 
Total Allele 1 
Allele 2 
(Heterozygous) 
Allele 2 
(Homozygous) 
Periodontal 
status 
Healthy to mild Count 18 2 1 21
% within Periodontal status 85.7% 9.5% 4.8% 100.0%
Moderate to severe Count 16 2 1 19
% within Periodontal status 84.2% 10.5% 5.3% 100.0%
Total Count 34 4 2 40
% within Periodontal status 85.0% 10.0% 5.0% 100.0%
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square .018(a) 2 .991
Likelihood Ratio .018 2 .991
Linear-by-Linear 
Association .015 1 .902
N of Valid Cases 
40   
a  4 cells (66.7%) have expected count less than 5. The minimum expected count is .95. 
 
 
 
 Periodontal status * IL-1A Crosstabulation 
 
  
IL-1A 
Total Allele 1 
Allele 2 
(Heterozygous) 
Periodontal 
status 
Healthy to mild Count 39 9 48
% within Periodontal status 81.3% 18.8% 100.0%
Moderate to severe Count 26 19 45
% within Periodontal status 57.8% 42.2% 100.0%
Total Count 65 28 93
% within Periodontal status 69.9% 30.1% 100.0%
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.081(b) 1 .014    
Continuity 
Correction(a) 5.017 1 .025    
Likelihood Ratio 6.172 1 .013    
Fisher's Exact Test     .023 .012 
Linear-by-Linear 
Association 6.016 1 .014    
N of Valid Cases 93      
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 13.55. 
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 Periodontal status * IL-1A Crosstabulation 
 
  
IL-1A 
Total Allele 1 Allele 2 
Periodontal 
status 
Healthy to mild Count 39 11 50
% within Periodontal status 78.0% 22.0% 100.0%
Moderate to severe Count 26 23 49
% within Periodontal status 53.1% 46.9% 100.0%
Total Count 65 34 99
% within Periodontal status 65.7% 34.3% 100.0%
 
 
  
 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.826(b) 1 .009    
Continuity 
Correction(a) 5.765 1 .016    
Likelihood Ratio 6.935 1 .008    
Fisher's Exact Test     .011 .008 
Linear-by-Linear 
Association 6.757 1 .009    
N of Valid Cases 99      
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 16.83. 
 
 Periodontal status * IL-1B Crosstabulation 
 
  
IL-1B 
Total Allele 1 
Allele 2 
(Heterozygous) 
Periodontal 
status 
Healthy to mild Count 18 2 20
% within Periodontal status 90.0% 10.0% 100.0%
Moderate to severe Count 16 2 18
% within Periodontal status 88.9% 11.1% 100.0%
Total Count 34 4 38
% within Periodontal status 89.5% 10.5% 100.0%
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .012(b) 1 .911    
Continuity 
Correction(a) .000 1 1.000    
Likelihood Ratio .012 1 .911    
Fisher's Exact Test     1.000 .656 
Linear-by-Linear 
Association .012 1 .912    
N of Valid Cases 38      
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.89. 
 
 
 
 
 
 
 Periodontal status  *IL-1B Crosstabulation  
 
  
IL-1B 
Total Allele 1 Allele 2 
Periodontal 
status 
Healthy to mild Count 18 3 21
% within Periodontal status 85.7% 14.3% 100.0%
Moderate to severe Count 16 3 19
% within Periodontal status 84.2% 15.8% 100.0%
Total Count 34 6 40
% within Periodontal status 85.0% 15.0% 100.0%
 
 
  
 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .018(b) 1 .894    
Continuity 
Correction(a) .000 1 1.000    
Likelihood Ratio .018 1 .894    
Fisher's Exact Test     1.000 .619 
Linear-by-Linear 
Association .017 1 .896    
N of Valid Cases 40      
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.85. 
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